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Dawn R. Wagenknecht 
EXPLORATION OF ENDOTHELIAL CELL INVASION AND RESPONSES TO 
NICOTINE AND ARGININE BY STREPTOCOCCUS MUTANS SEROTYPE K STRAINS 
IN A SUCROSE-INDUCED BIOFILM LIFESTYLE 
Streptococcus mutans, an inhabitant of oral biofilm or dental plaque, adheres to 
the tooth surface via protein antigen I/II (PA I/II). Pathologic lesions of atherosclerosis  
(AT) and infective endocarditis (IE) harbor S. mutans. Serotypes f and k strains with 
collagen binding protein genes cbm and cnm are uncommon in the mouth, but these are 
the most prevalent S. mutans strains in AT and IE tissues and can invade endothelial 
cells (EC) in vitro. Tobacco use increases the risk for cardiovascular and oral diseases. 
Oral S. mutans encounter many substances including nicotine. Arginine is present in 
saliva and the EC glycocalyx that coats and protects ECs from shear forces of blood 
flow. Prior studies demonstrated arginine alters S. mutans biofilm. This work 
characterizes S. mutans serotype k strains and serotype c strains, the most prevalent in 
the mouth. The effects of nicotine and arginine on biofilm mass, metabolic activity and 
EC invasion were investigated. Biofilm production by serotypes c and k strains did not 
differ; there were no differences in responses to nicotine and arginine between these 
serotypes. Increased production of biofilm was associated with the cbm and cnm genes. 
Nicotine increased biofilm for all strains whereas arginine plus nicotine reduced bacteria 
and the extracellular polymeric substances. Previous EC invasion studies were 
performed with planktonic cultures of S. mutans; therefore, EC invasion by biofilm was 
evaluated. Significant factors for EC invasion by S. mutans are presence of the cbm 
gene and lack of PA I/II expression on the bacterial cell surface. Presence of the cnm 
gene increased EC invasion by biofilm but not planktonic cells. Planktonic cells of six 
strains invaded better than biofilm, whereas four strains showed increased invasion by 
biofilm cells. Neither nicotine nor arginine significantly altered the ability of S. mutans 
biofilm cells to invade ECs. Not all strains with cbm or cnm and no PA I/II expression 
invaded EC. A strain with PA I/II expression and without cbm and cnm genes invaded 
EC. While cbm, cnm and PA I/II expression are predictors of EC invasion, additional 
mechanisms for EC invasion by S. mutans remain to be revealed.  
 
Richard L. Gregory, Ph.D., Chair 
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Cardiovascular diseases (CVD), including atherosclerosis (AT), are a leading 
cause of death in developed countries. Tobacco use is a well-documented risk factor for 
CVD and has been linked with oral diseases such as periodontitis and dental caries 
(Friedewald, Kornman et al. 2009, Benedetti, Campus et al. 2013). A direct causal link 
between AT-CVD and periodontal disease (PD) has not been established but an indirect 
link is supported by the many shared risk factors of the two diseases, i.e., diabetes 
mellitus, systemic inflammation, family history, advanced age, male gender, and 
smoking (Friedewald, Kornman et al. 2009). Demonstrating the importance of this 
association, a recent Editors’ consensus simultaneously published in the American 
Journal of Cardiology and Journal of Periodontology informed both medical and dental 
practitioners of this significant link (Friedewald, Kornman et al. 2009, Friedewald, 
Kornman et al. 2009). A 2012 statement by the American Heart Association after review 
of 537 peer-reviewed publications supported an association between periodontal 
disease and atherosclerotic vascular disease but the reported observational studies 
failed to support a causative relationship (Lockhart, Bolger et al. 2012).  
Longitudinal population-based studies with large numbers of participants further 
support an association, if not a causal relationship between CVD and oral health. 
Studies of a Swedish cohort of 8999 subjects with a median of 17-year follow-up found 
an increased incidence of CVD for subjects with a poor response to periodontal 
treatment compared with responders (p<0.001) (Holmlund, Lampa et al. 2017). Within 
this cohort, oral health represented by the number of remaining teeth was related to 
incident myocardial infarction and heart-failure (Holmlund, Lampa et al. 2017). Inasmuch 
as the measure of this study was tooth loss, it should be noted that tooth loss can be 
related to dental caries as well as PD. Evidence from the case-control Periodontitis and 
Its Relation to Coronary Artery Disease (PAROKRANK) study supported an association 
between periodontitis and first myocardial infarction even after adjustment for 
confounding factors including participant’s smoking status (Ryden, Buhlin et al. 2016). In 
a broader evaluation of oral health, a 44-year epidemiological study of the oral health of 
1393 randomly selected subjects in Stockholm reported that the quality of oral health is a 
risk indicator for death by CVD (Jansson, Kalkali et al. 2018).  
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Inflammation is a common key factor in all stages of both CVD and PD. The 
incidence of CVD increases in the presence of chronic inflammatory diseases such as 
Lupus erythematosus, rheumatoid arthritis and PD (Frostegard 2013). Injury of the 
vascular endothelium is likely an early pathophysiological event in the development of an 
atherosclerotic plaque. Inception of the atherosclerotic plaque is marked by activation of 
the endothelial cells and production of pro-inflammatory cytokines leading to recruitment 
of immune cells and triggering additional cytokine production at the endothelium  
(Spagnoli, Bonanno et al. 2007, Libby 2012).  
Considerable evidence suggests that infection is a risk factor for AT and plays a 
role in the chronic inflammatory processes of the disease (Rosenfeld and Campbell 
2011, Campbell and Rosenfeld 2015). Indeed the molecular footprints of oral bacteria 
have been identified in extra-oral tissues including atherosclerotic plaques (Nakano, 
Nemoto et al. 2007, Nakano, Nemoto et al. 2009, Reyes, Herrera et al. 2013, Lanter, 
Sauer et al. 2014). While many studies of AT and CVD have focused on periodontal 
pathogens, Streptococcus mutans, the causative agent of dental caries has also been 
identified in atherosclerotic plaques and in heart valves from cases of infective 
endocarditis (IE) (Nakano, Nemoto et al. 2007, Nakano, Nemoto et al. 2009). Kozarov, 
et al. detected S. mutans DNA in 22.5% of atherosclerotic plaques obtained from a 
young population (mean age 26.8 ± 8.2 years) and found twice as many atheromatous 
plaques (44%) contained evidence of S. mutans DNA in an elderly population (mean age 
67 years) (Kozarov, Sweier et al. 2006). Nakano and colleagues reported detection of S. 
mutans in 74% of atheromatous plaques from elderly Japanese patients (average age 
71 years) (Nakano, Inaba et al. 2006, Nomura, Nakano et al. 2006). These data are 
suggestive of interactions between S. mutans and the endothelial cells.  
In addition to reports of S. mutans in atheromatous plaques and heart valves, this 
species of bacteria is implicated in intra-cerebral hemorrhage, cerebral microbleeds and 
cognitive impairment  (Nakano, Hokamura et al. 2011, Miyatani, Kuriyama et al. 2015, 
Watanabe, Kuriyama et al. 2016, Inenaga, Hokamura et al. 2018). S. mutans has also 
been correlated with IgA nephropathy and non-alcoholic steatohepatitis (Naka S Fau - 
Nomura, Nomura R Fau - Takashima et al. 2014, Misaki, Naka et al. 2015, Misaki, Naka 
et al. 2016, Naka, Hatakeyama et al. 2016). Ulcerative colitis and inflammatory bowel 
disease are reported to be correlated with or aggravated by S. mutans (Kojima, Nakano 
et al. 2012, Kojima, Nomura et al. 2014). Undeniably, S. mutans survives outside the 
oral cavity and is involved in extra-oral infection of several organ systems. 
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STREPTOCOCCUS MUTANS 
Strains of S. mutans are serotyped according to specific polysaccharides found 
on the cell wall. Cell surface polysaccharides of S. mutans are comprised of a rhamnose 
backbone with glucose side chains. The ratio of glucose to rhamnose is drastically 
decreased in serotype k strains compared to strains of serotypes c, e and f.  As a 
consequence, until recently serotype k strains were identified as non-serotype c/e/f S. 
mutans (Nakano and Ooshima 2009). Serotype c strains are the most prevalent strains 
of S. mutans found in the oral cavity. Serotype k strains comprise 1.5% of the S. mutans 
isolated from the oral cavities of healthy subjects. In comparison, for patients with 
cardiovascular (CV) disease, serotype k strains are significantly increased in frequency 
within the oral cavity (10.3%, p<0.05) (Nakano, Nemoto et al. 2007). Patients with CV 
disease are more likely to harbor multiple S. mutans serotypes in the oral cavity 
compared to healthy subjects (53.8% versus 25.0%, respectively) (Nakano, Nemoto et 
al. 2007). In addition, Nakano et al. reported that S. mutans serotype k strains were 
present in 9.1% of heart valve and 25% of atheromatous tissue specimens and were 
increased in prevalence in diseased CV tissue compared to the oral cavities of the same 
patients (Nakano, Nemoto et al. 2007). These data suggest that S. mutans serotype k 
strains may adhere to, or interact with, endothelial cells at increased frequency 
compared to serotype c strains which are the most prevalent in the oral cavity.  
The presence of S. mutans in atheromatous plaque may result from 
phagocytosis by monocytes at the endothelial cell surface of blood vessels followed by 
extravagation of the monocytes through the endothelial cell layer. Alternatively, collagen 
binding proteins (CBP) on the surface of S. mutans may facilitate binding directly to the 
endothelium. Two CBP, Cnm and Cbm, have been described in S. mutans (Abranches, 
Miller et al. 2011, Lapirattanakul, Nomura et al. 2013). These proteins are the products 
of cnm and cbm genes, which are found primarily in serotype f and k strains of S. 
mutans (Lapirattanakul, Nomura et al. 2013). Interestingly, serotypes f and k are 
increased in prevalence in the atherosclerotic plaques compared to the oral cavity of the 
same subjects with CVD and the oral cavities of normal, healthy controls (Nakano, 
Nemoto et al. 2007). In addition to binding collagen, cnm  and cbm genes confer S. 
mutans with the ability to adhere to and invade endothelial cells (Abranches, Miller et al. 
2011, Nomura, Nakano et al. 2012). S. mutans strains that express cnm  and cbm are 
able to invade non-phagocytic cells, a trait directly related to chronic and systemic 
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infections (Nomura, Nakano et al. 2009, Nomura, Nakano et al. 2012, Aviles-Reyes, 
Miller et al. 2017).  
Previous studies of endothelial cell invasion by S. mutans strains with CBP were 
performed with S. mutans growing in planktonic or a free-living bacterial cell conditions 
(Abranches, Miller et al. 2011, Lapirattanakul, Nakano et al. 2011, Nomura, Nakano et 
al. 2012, Lapirattanakul, Nomura et al. 2013). The natural habitat of S. mutans is within 
dental plaque which is a multi-species oral biofilm formed on hard surfaces of teeth 
(Lemos, Palmer et al. 2019). Indeed, the ability to form and reside in biofilms is an 
important virulence factor for S. mutans in dental caries (Matsumoto-Nakano 2018). 
Within the biofilm, three core attributes of S. mutans are the ability to synthesize 
extracellular polymers of glucan from sucrose, metabolize carbohydrates into organic 
acids, and flourish under low pH conditions and other environmental stresses (Lemos, 
Palmer et al. 2019). Synthesis of the biofilm extracellular matrix by S. mutans requires 
upregulation of many genes (i.e., glucosyltransferases, glucan biding proteins, etc.) that 
serve no purpose for free-living cells except as receptors for future surface attachment. 
An in vitro comparative transcriptome analysis found 12% of S. mutans genes showed 
significant differential expression between S. mutans biofilm and free-living cells 
(Shemesh, Tam et al. 2007). Indeed, differential gene expression was observed based 
upon the carbohydrate(s) and surface provided for S. mutans biofilm production 
(Shemesh, Tam et al. 2007, Shemesh, Tam et al. 2010). These data suggest that 




Smoking is a well-known risk factor for both CVD and oral diseases, including 
dental caries. The direct mechanisms for smoking induced disease are yet to be fully 
elucidated, but the indirect effects of smoking are many. For example, mutans 
streptococci are increased in the saliva of smokers compared to non-smokers (Sakki 
and Knuuttila 1996). An increase in streptococcus 16S rRNA in oral washes of smokers 
compared to never smokers suggests that smoking alters the oral biome to the 
advantage of streptococcal species (Wu, Peters et al. 2016). Nicotine, a component of 
tobacco, causes the addictive behavior of smoking and increases biofilm growth of S. 
mutans serotypes c, e and f (Huang, Li et al. 2012). The effects of nicotine on S. mutans 
serotype k have not been investigated. In vivo and in vitro studies demonstrate an 
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increase in S. mutans in the oral cavity of smokers. This increased bacterial cell count 
enhances the opportunity for S. mutans to enter the blood stream through injury caused 
by mastication and daily oral hygiene practices. 
 
ARGININE 
The basic amino acid, arginine, is abundant in a wide range of foods and in 
saliva. In addition, relevant to this project, arginine is present in the glycoprotein-
polysaccharide covering  (glycocalyx) at the endothelial cell surface (Tarbell and Pahakis 
2006, Flam, Eichler et al. 2007). Arginine alters S. mutans biofilm formation and 
structure by reducing or altering adhesion properties of the extracellular polysaccharides 
(Sharma, Lavender et al. 2014, Zheng, Cheng et al. 2015). These properties have 
prompted addition of arginine to toothpaste to augment the benefit of fluoride in 
suppressing S. mutans growth in oral biofilm (Zheng, Cheng et al. 2015). Arginine 
induces changes in biofilm elicited by an increase in biomass (bacteria cell number) and 
decrease in production of extracellular polymeric substances (EPS) by the bacteria 
(Zheng, Cheng et al. 2015). The combination of fluoride and arginine may be of greater 
benefit to smokers than to non-smokers as it potentially can reduce nicotine enhanced 
S. mutans biofilm growth. The presence of arginine in the oral cavity and at the 
endothelial cell surface as well as its effects on reducing S. mutans biofilm leads to 
speculation whether arginine might negate the biofilm enhancing effects of nicotine. 
 
RESEARCH SUMMARY 
The following chapters will first review the effects of nicotine on oral bacteria and 
tissues. Since serotype k strains of S. mutans have been implicated in CVD and other 
extra-oral infections, my work focuses on 33 serotype k strains of S. mutans and the 
biofilm lifestyle of these strains. The effects of nicotine and arginine on biofilm production 
by serotype k strains will be presented and discussed. In addition, endothelial cell 
invasion by both free-living S. mutans and S. mutans growing in biofilm will be 
compared. Finally, the effects of nicotine and arginine on the ability of S. mutans biofilm 
cells to invade endothelial cells will be explored. I hope these studies expand the 
literature about the effects of lifestyle on S. mutans responses to certain environmental 
exposures and endothelial cell invasion. Moreover, I am optimistic that the reader will 
find food for thought, speculation, and inspiration for additional experiments within the 
following pages.  
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Chapter Two 
EFFECTS OF NICOTINE ON ORAL MICROORGANISMS, HUMAN TISSUES 
AND THE INTERACTIONS BETWEEN THEM 
 
INTRODUCTION 
Cigarette smoking is a preventable risk factor for many cancers and chronic 
diseases. The 2014 Surgeon General’s report: The Health Consequences of Smoking - 
50 Years of Progress found sufficient evidence to add liver and colorectal cancers to the 
long list of cancers causally related to cigarette smoking (National Center for Chronic 
Disease, Health Promotion Office on et al. 2014). Moreover, chronic diseases such as 
stroke, cardiovascular disease, respiratory diseases and periodontitis have long been 
linked to smoking. The 2014 report found sufficient evidence to add age related macular 
degeneration, diabetes, rheumatoid arthritis, ectopic pregnancy and erectile dysfunction 
to the catalog of chronic conditions caused by cigarette smoking. Additionally, the 2014 
report found sufficient evidence to link maternal smoking to structural birth defects of 
oral-facial clefts (National Center for Chronic Disease, Health Promotion Office on et al. 
2014). 
The burning of tobacco, as in smoking, produces a complex mixture of over 7000 
compounds (National Center for Chronic Disease, Health Promotion Office on et al. 
2014). Nicotine, an alkaloid, is the primary bioactive and addictive agent in tobacco. 
Nicotine and its metabolites are found in blood, saliva, urine and breast milk of smokers 
(Shafagoj, Mohammed et al. 2002, Jacob, Golmard et al. 2015). Salivary nicotine levels 
vary by mode and duration of tobacco exposure such as cigarette smoking (median 27 
ug/ml, range 4 – 207 ug/ml) (Jacob, Golmard et al. 2015), water pipe smoking (283.5 
ng/ml ± 75 ng/ml) (Shafagoj, Mohammed et al. 2002), and electronic cigarette (e-cig) 
smoking (541 ug/L, range 291-2553 ug/L) (Papaseit, Farre et al. 2017). Levels of 
nicotine in the blood and saliva vary depending upon the number and type of cigarettes 
smoked. Smokers of menthol cigarettes had slower rates of salivary nicotine metabolism 
than smokers of non-menthol cigarettes (Fagan, Pokhrel et al. 2016). Levels of nicotine 
and it’s metabolites are reported to be 100-fold greater in oral fluid compared to blood, 
and breast milk contains 25% of the nicotine concentrations found in blood (Jacob, 
Golmard et al. 2015, Papaseit, Farre et al. 2017). The nicotine concentrations in breast 
milk were significantly associated with salivary nicotine concentration and cigarette 
consumption (Jacob, Golmard et al. 2015). This suggests that in addition to potential 
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second-hand smoke exposure, breast-fed infants of mothers who smoke are directly and 
systemically exposed to nicotine from an early age.  
Significant increases in the use of non-conventional tobacco products such as e-
cigs and hookah are reported among high school students (Marshall, Lotfipour et al. 
2016). Despite a drop in the use of conventional tobacco products, the rate of tobacco 
consumption remained constant in the school-age population between 2011 and 2014 
(Marshall, Lotfipour et al. 2016). After conventional cigarette smoking, blood plasma 
nicotine concentrations ranged from 2.9 to 16.4 ug/L compared to 0 – 14.5 ug/L following 
e-cig use (Papaseit, Farre et al. 2017). A small crossover study of cigarette smokers 
naïve to e-cig use reported oral nicotine concentrations higher after cigarette smoking 
compared to e-cig smoking (728 ug/L, range 241 – 3960 ug/L and 541 ug/L, range 291-
2553 ug/L, respectively) (Papaseit, Farre et al. 2017). The concentration of nicotine in e-
cig cartridges varies by product; thus, plasma and salivary nicotine concentrations may 
be higher depending upon the e-cig product chosen. 
The oral microbiome of smokers is directly exposed to nicotine at high levels, and 
for sustained periods. Recent literature on the effects of nicotine on the oral bacteria 
associated with dental diseases such as periodontitis and caries will be summarized in 
this review. In addition, the roles of nicotine and oral bacteria in oral and cardiovascular 
diseases will be explored. 
 
PERIODONTAL PATHOGENS 
Many studies report that smoking is a risk factor for PD (Friedewald, Kornman et 
al. 2009, National Center for Chronic Disease, Health Promotion Office on et al. 2014). 
PD involves pathological inflammation of the gingiva, alveolar bone, periodontal ligament 
and cementum (How, Song et al. 2016). In the United States, PD affects about 50% of 
adults over 30 years of age is the primary cause of tooth loss in this age group (Bostanci 
and Belibasakis 2012). Smoking is associated with increased dental plaque formation as 
well as shifts in the composition of the oral bacteria within periodontal plaque, both of 
which may increase risk for PD (Zambon, Grossi et al. 1996, Kamma, Nakou et al. 1999, 
Eggert, McLeod et al. 2001, Haffajee and Socransky 2001). Smoking increases the 
pathogenicity of certain microorganisms and elevates the amount of free iron in the 
mouth thereby supporting increased growth of the oral bacteria (Zambon, Grossi et al. 
1996, Kamma, Nakou et al. 1999, Weinberg 2000, Eggert, McLeod et al. 2001, Haffajee 
and Socransky 2001, Weinberg 2009). In addition, smoking decreases oxygen tension 
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and induces changes in the gingival vasculature (Kumar 2012). All of these factors can 
potentially modify cytokines, chemokines and growth factors in the oral cavity thereby 
altering subgingival bacterial composition (Kumar 2012). Moreover, it was proposed that 
smoking increased the amount of bacterial pathogen load by inducing physiological 
changes in the body, increasing bacterial virulence or compromising the immune system 
(Bagaitkar, Demuth et al. 2008).  
In a study of 1426 subjects, Zambon et al. used indirect immunofluorescence 
microscopy to detect subgingival infection by select periodontal pathogens. Smokers 
had higher prevalence of Aggregatibacter actinomycetemcomitans, Tannerella forsythia 
and Porphyromonas gingivalis compared to non-smokers  (Zambon, Grossi et al. 1996). 
The prevalence of Treponema denticola was also increased in smokers (Umeda, Chen 
et al. 1998). Other studies support increased prevalence of P. gingivalis and T. denticola 
in smokers compared to non-smokers (Umeda, Chen et al. 1998, Eggert, McLeod et al. 
2001, Socransky and Haffajee 2005). Van Winkelhoff et al. anaerobically cultured 
samples from the deepest site of each quadrant and found increased prevalence of 
Prevotella intermedia and Prevotella nigrescens from smokers (P=0.05) compared to 
non-smokers (van Winkelhoff, Bosch-Tijhof et al. 2001). Subgingival plaque samples 
obtained from 200 subjects free of systemic disease and PD revealed that dental plaque 
from smokers harbored significantly more diverse, and commensal-poor, anaerobic 
bacteria than non-smokers (Mason, Preshaw et al. 2015). The pathogens found in oral 
plaque are more likely to be associated with future disease for smokers than for non-
smokers (Mason, Preshaw et al. 2015). Joshi et al. also concluded that smokers are 
more likely to have gingival inflammation than non-smokers due to greater microbial 
diversity in the oral biofilm communities from smokers (Joshi, Matthews et al. 2014). 
Similar changes in biofilm composition secondary to smoking are reported in the peri-
implant microbiome (Tsigarida, Dabdoub et al. 2015). Further, smoking alters the oral 
microbial flora without increasing the amount of dental plaque suggesting that the 
bacterial composition rather than the quantity of dental plaque is an important factor for 
PD (Palmer, Wilson et al. 2005). Smoking not only increases the risk for periodontitis but 
it also increases resistance to treatment; however, healthier biofilm composition can be 
achieved six months after smoking cessation (Palmer, Wilson et al. 2005, Fullmer, 
Preshaw et al. 2009).  
P. gingivalis, an obligate anaerobic bacterium, along with T. denticola and T. 
forsythia form the red bacterial complex, which has been shown to cause PD 
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(Mahanonda, Seymour et al. 1991, How, Song et al. 2016). Cigarette smoke extract 
(CSE) and nicotine increase the pathogenicity of P. gingivalis by enhancing adhesion of 
P. gingivalis to epithelial cell monolayers (Cogo, Calvi et al. 2009, Bagaitkar, Demuth et 
al. 2010). Major fimbrial protein (FimA) facilitates P. gingivalis adherence to epithelial cell 
monolayers and is upregulated by CSE (Bagaitkar, Demuth et al. 2010). Bagaitkar et al. 
reported that CSE augments P. gingivalis biofilm formation by increasing FimA, which 
then promotes interspecies interactions. For example, P. gingivalis adherence to 
Streptococcus gordonii increases three-fold in the presence of CSE (Bagaitkar, Daep et 
al. 2011) . Zeller et al. found that smoking increased the pathogenicity of P. gingivalis by 
impairing host IgG response to the pathogen (Zeller, Hutcherson et al. 2014). This study 
reported significant increases of oral and systemic P. gingivalis infections in smokers, 
which may be a consequence of decreased host IgG response to P. gingivalis (Zeller, 
Hutcherson et al. 2014). Moreover, synergistic effects between nicotine and toxins 
produced by P. gingivalis lead to PD  (Sayers, Gomes et al. 1997). In contrast, other 
studies showed no correlation between smoking and changes in the supragingival and 
subgingival microflora (Preber, Bergstrom et al. 1992, Van der Velden, Varoufaki et al. 
2003). 
In addition to its effects on the oral microflora, smoking has adverse effects on 
tissues of the oral cavity. A 3-year longitudinal study of 81 subjects compared the 
outcome of regular maintenance therapy for chronic periodontitis for smokers and non-
smokers. Although not statistically significant, smokers experienced greater clinical 
attachment loss and deeper periodontal pockets than non-smokers. (Fisher, Kells et al. 
2008). After just 24 hours of in vitro exposure to millimolar concentrations of nicotine, 
gingival fibroblast adhesion to the root surface was significantly reduced and fibroblasts 
that attached to the root surface failed to proliferate (Esfahrood, Zamanian et al. 2015). 
Nicotine has been shown to induce apoptosis of gingival fibroblasts through generation 
of reactive oxygen species and activation of the caspase-3 dependent pathway (Kang, 
Park et al. 2011). In contrast, nicotine through the endoplasmic reticulum stress pathway 
induces necrosis of human periodontal ligament cells and periodontal tissue destruction 
by means of Akt, ERK, p38, JNK MAPK and NF-κβ pathways (Lee, Kang et al. 2012). 
Nicotine significantly inhibits migration of human gingival fibroblast and periodontal 
ligament cells, induces production of pro-fibrotic molecules (CCN2/CTGF and TGF-β1) 
and increases production of tissue inhibitor of metalloproteinase-1.  These actions alter 
the extra cellular matrix (ECM) remodeling systems of periodontal cells resulting in 
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periodontal fibrosis due to increased accumulation of type I collagen in the ECM 
(Takeuchi-Igarashi, Kubota et al. 2016). 
Nicotine also alters inflammatory responses to bacterial infection. Contrary to the 
expected inflammatory response, CSE-exposed P. gingivalis induced a lower pro-
inflammatory response (TNF-α, IL-6, IL-12) and higher anti-inflammatory response (IL-
10) from human monocytes and peripheral blood mononuclear cells than unexposed P. 
gingivalis (Bagaitkar, Williams et al. 2009, Bagaitkar, Demuth et al. 2010). Increased 
production of the pro-inflammatory cytokines, IL-1β and IL-8, was reported subsequent 
to nicotine treatment of human gingival epithelial and periodontal ligament cells (Wu, 
Zhou et al. 2014). These findings are consistent with the clinical observations that 
smokers with severe PD often do not manifest obvious signs of inflammation. 
 
S. MUTANS AND DENTAL CARIES 
Dental caries is caused by acid induced mineral loss from the tooth structure 
(Hayes, Cheng et al. 2017). In 2007, 91% of American adults aged more than twenty 
experienced dental caries, and 27% had untreated carious teeth (Dye, Thornton-Evans 
et al. 2015). S. mutans and Lactobacillus species are considered the main causative 
agents of dental caries. The oral cavities of caries-affected subjects harbor 70 times 
more S. mutans than caries-free subjects (Peterson, Snesrud et al. 2013). The 
cariogenicity of S. mutans is related to its ability to produce lactic acid from available 
carbohydrates leading to demineralization of the tooth structure (Moynihan and Petersen 
2004). Not only does S. mutans produce acid, but it survives in highly acidic 
environments (Moynihan and Petersen 2004). S. mutans attaches to the tooth structure 
either by glucosyltransferase (Gtf) enzymes which convert sucrose to glucan or by a 
unique interaction with salivary proteins and agglutinin (Ahn and Burne 2007, Wen, 
Yates et al. 2010). Biofilm on the tooth surface is established by bacterial interaction with 
salivary components and with other microorganisms (Zijnge, van Leeuwen et al. 2010). 
Many studies indicate that the incidence of dental caries is higher for smokers (Aguilar-
Zinser, Irigoyen et al. 2008, Avsar, Darka et al. 2008, Campus, Cagetti et al. 2011). In 
vitro studies demonstrate that nicotine and cigarette smoke condensate (CSC) increase 
the cariogenicity and growth of S. mutans. Huang et al. investigated the effects of 
nicotine on seven S. mutans strains including UA159, UA130, 10449, A32-2, NG8, LM7, 
and OMZ175 and found that cultures grown in trypticase soy broth (TSB) plus 1% 
sucrose had increased metabolic activities and biofilm quantity in the presence of 
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nicotine (0.5 – 8.0 mg/ml). Most strains exhibited maximum metabolic activity in 8 mg/ml 
nicotine; A32-2 peaked at 16 mg/ml nicotine. Peak biofilm mass was found at 4 or 8 
mg/ml nicotine except for LM7 biofilm which peaked at 1 mg/ml nicotine. Thirty-two 
mg/ml nicotine was bactericidal for all strains (Huang, Li et al. 2012). Confocal scanning 
laser microscopy of S. mutans biofilm demonstrated that both bacterial cell numbers and 
extracellular polysaccharides (EPS) increased with increasing nicotine dose (Huang, Li 
et al. 2015). Nicotine upregulates Gtf and glucan binding protein (Gbp) A expression by 
planktonic cells (2.2 and 4-fold, respectively) but had no effect on GbpB. In contrast, 
GbpB was decreased by 75% in biofilm grown with 1% sucrose and nicotine, while Gtf 
and GbpA were unchanged (Huang, Li et al. 2015). Nicotine did not directly affect 
specific lactate dehydrogenase (LDH) activity of the biofilm; however, the overall 
concentration of lactate was significantly higher due to the larger number of biofilm cells 
(Huang, Li et al. 2015).  
In dual-species experiments, Li et al. demonstrated that nicotine did not have a 
significant effect on Streptococcus sanguinis in either mono- or dual-species biofilm, 
whereas nicotine significantly increased S. mutans bacterial cell mass and EPS in both 
mono- and dual-species biofilm (Li, Huang et al. 2014). By using a sortase-defective 
strain of S. mutans, Li and colleagues demonstrated decreased sucrose and saliva-
induced biofilm formation in the presence of nicotine compared to the wild-type strain. 
Biofilm formation increased significantly with low concentrations of nicotine compared to 
biofilm without nicotine (Li, Huang et al. 2013). In the presence of 1 mg/ml nicotine, the 
biofilm was more dense; ldh, nlmC and phosphotransferase system (PTS)-associated 
virulence genes were upregulated; and sucrose metabolism increased lactic acid 
production leading to a reduction in pH creating an environment favoring caries 
development (Li, Huang et al. 2016). A recent study in Dr. Rich Gregory’s lab that 
investigated S. mutans isolates from oral washes collected from 10 smokers and 10 non-
smokers supports the previous study. El-ezmerli and Gregory found increased biofilm 
formation from S. mutans isolates in oral washes from smokers compared to isolates 
from non-smokers (El-ezmerli & Gregory, unpublished). 
Experiments done in my lab investigated the effects of CSC and nicotine on S. 
mutans and the efficacy of certain agents to inhibit nicotine-enhanced S. mutans biofilm 
formation. Mutacins are bacteriocins produced by S. mutans to favor its growth over 
other bacterial species in the biofilm. Nicotine at doses of 2 and 4 mg/ml in the culture 
broth significantly increased S. mutans production of bacteriocins (Shepherd et. al., 
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unpublished). Naturally occurring dietary substances exert inhibitory effects on nicotine 
enhanced S. mutans biofilm formation. A polyphenol found in green tea inhibited 
nicotine-induced S. mutans biofilm formation (Foltz et al. and Taylor et. al., unpublished). 
Sodium chloride, potassium chloride and potassium iodide salts cause a decrease in 
nicotine stimulated S. mutans biofilm as measured by crystal violet (Balhaddad & 
Gregory, unpublished). In addition, 90 mg/mL of garlic significantly decreased the 
amount of nicotine-induced S. mutans biofilm (Dietl et. al., unpublished). These data 
suggest the potential of dietary supplementation to combat increased risk of dental 
caries in smokers.  
 
OTHER BACTERIAL SPECIES 
Aside from those bacteria associated with PD and caries, nicotine also affects 
other oral microbes (Table 2.1). Dubois et al. investigated the stimulating and inhibitory 
effect of nicotine on biofilm growth of Candida albicans and five species of oral bacteria, 
Lactobacillus casei, Actinomyces viscosus, Actinomyces naeslundii, Rothia dentocariosa 
and Enterococcus faecalis. The minimum biofilm inhibitory concentration (MBIC) for 
these species was 16 mg/ml of nicotine except for E. faecalis, which was 32 mg/ml. The 
MBIC for all species was 16 mg/ml nicotine. The total amount of growth increased 
through 8 mg/ml of nicotine for L. casei, A. viscosus, R. dentocariosa, and C. albicans, 
while the total growth for E. faecalis increased up to 16 mg/ml. A. naeslundii growth was 
diminished by 8 mg/ ml of nicotine and completely inhibited by 16 mg/ml (Dubois, 
Bennett et al. 2014). Huang and colleagues found that S. gordonii had significantly 
increased planktonic and biofilm growth when 1 to 4 mg/ml of nicotine was added to the 
culture media (Huang, Li et al. 2014). 
Scardovia wiggsiae, discovered in 2011, is significantly associated with severe 
early childhood caries (Tanner, Mathney et al. 2011). As in other species of oral 
bacteria, biofilm formation by S. wiggsiae increased in a nicotine dose dependent 
manner from 0.5 to 8 mg/ml of nicotine. The MBIC of S. wiggsiae was 16 mg/ml of 
nicotine, and as observed in other species, 32 mg/ml of nicotine was bactericidal. The 
amount of nicotine-induced S. wiggsiae biofilm formation on human enamel was greater 
than on human dentin (Balhaddad and Gregory, unpublished). These findings suggest 
that nicotine load in saliva acquired from first- or second-hand smoke might increase the 
risk of early childhood caries.  
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CANDIDA ALBICANS AND STOMATITIS 
Denture stomatitis, characterized by inflammation and erythema in the oral cavity 
of denture wearers, occurs in 11% to 67% of patients with complete dentures (Arendorf 
and Walker 1987, Webb, Thomas et al. 1998, Webb, Thomas et al. 1998). C. albicans 
infection of the denture is the primary cause of stomatitis; however, other factors 
including dietary habits, denture trauma, lack of oral hygiene, allergy and systemic 
diseases contribute to the condition (Arendorf and Walker 1987, Webb, Thomas et al. 
1998, Webb, Thomas et al. 1998). Nicotine increases the total growth and biofilm 
formation of C. albicans, which may increase the risk of denture stomatitis for tobacco 
users (Dubois, Bennett et al. 2014). Ashkanane et al. demonstrated that 4 mg/ml of 
nicotine significantly increased co-aggregation of C. albicans and S. mutans 
(Ashkanane, Gomez et al. 2017). Upregulation of S. mutans production of GtfB in the 
presence of nicotine was proposed as the mechanism for the increased co-aggregation 
(Huang, Li et al. 2015). GtfB increased co-aggregation of S. mutans and C. albicans by 
converting C. albicans to de facto glucan producers, thus increasing the cariogenicity of 
S. mutans (Ashkanane, Gomez et al. 2017).          
                              
ORAL BACTERIA AND CARDIOVASCULAR DISEASE 
CVDs, including AT, are a leading cause of death in developed countries, and 
tobacco use is a well-documented risk factor for CVD. A causal link between AT-CVD 
and PD has not been established, but AT-CVD and PD have shared risk factors such as 
diabetes mellitus, systemic inflammation, family history, advanced age, male gender, 
and smoking (Friedewald, Kornman et al. 2009). Inflammation is a key factor in all 
stages of both CVD and PD. The incidence of CVD increases in the presence of chronic 
inflammatory diseases such as Lupus, rheumatoid arthritis and PD (Frostegard 2013). 
Vascular endothelial injury is proposed as an early pathophysiological event of AT 
plaque formation which is marked by activation of the endothelial cells and production of 
pro-inflammatory cytokines leading to recruitment of immune cells and additional 
cytokine production (Spagnoli, Bonanno et al. 2007, Libby 2012). 
Considerable evidence suggests that chronic infection is a risk factor for AT and 
plays a role in the chronic inflammatory processes of the disease (Rosenfeld and 
Campbell 2011, Campbell and Rosenfeld 2015). The molecular footprints of oral bacteria 
have been identified in CV tissues including atherosclerotic plaques (Nakano, Nemoto et 
al. 2007, Nakano, Nemoto et al. 2009, Reyes, Herrera et al. 2013, Lanter, Sauer et al. 
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2014). P. gingivalis was identified by molecular and histological methods in excised 
aortic aneurysm specimens (Nakano, Wada et al. 2011). S. mutans has been identified 
in excised atherosclerotic plaques and in heart valves from cases of IE (Nakano, Inaba 
et al. 2006, Nomura, Nakano et al. 2006, Nakano, Nemoto et al. 2007, Nakano, Nemoto 
et al. 2009, Kozarov 2012). These data are suggestive of interactions between oral 
bacteria and vascular endothelial cells.  
Strains of S. mutans are serotyped as c, e, f and k according to specific 
polysaccharides found on the cell wall. S. mutans serotype c strains are the most 
prevalent serotype in oral biofilm, whereas serotype k strains comprise only 1.5% of the 
S. mutans isolated from the oral cavities of healthy subjects. In contrast, patients with 
CVD have significantly increased frequency of serotype k strains in the oral cavity 
(10.3%, p<0.05) and are more likely to harbor multiple S. mutans serotypes compared to 
healthy subjects (53.8% versus 25.0%, respectively) (Nakano, Nemoto et al. 2007). 
Nakano et al. reported S. mutans serotype k strains in 9.1% of excised heart valves and 
25% of atheromatous tissue specimens (Nakano, Nemoto et al. 2007). Further, serotype 
k strains were increased in prevalence in the diseased CV tissue compared to the oral 
cavities of the same patients (Nakano, Nemoto et al. 2007). These data suggest that 
serotype k may interact with endothelial cells at increased frequency compared to 
serotype c, the most prevalent in the oral cavity.  
Smoking is a well-accepted risk factor for both CVD and oral diseases, including 
dental caries. In addition to the in vitro biofilm findings with nicotine previously 
discussed, a clinical study reported increased mutans streptococci in the saliva of 
smokers compared to non-smokers (Sakki and Knuuttila 1996). An increase in 
streptococcal 16S rRNA in oral washes of smokers compared to never smokers 
suggests that smoking alters the oral biome to the advantage of streptococcal species 
(Wu, Peters et al. 2016). Nicotine increases biofilm growth of S. mutans serotypes c, e 
and f (Huang, Li et al. 2012). The effects of nicotine on S. mutans serotype k are not 
different from serotype c strains (manuscript in preparation). These effects may be 
associated with increased oral biofilm in smokers. Increased biofilm growth enhances 
the opportunity for S. mutans to enter the blood stream through injury caused by 
mastication or daily oral hygiene practices. 
S. mutans found within the AT plaque may be a consequence of monocyte 
phagocytosis and extravagation through the endothelial cell layer of vascular tissues. 
Alternatively, collagen binding proteins (CBP), Cnm and Cbm, on the surface of S. 
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mutans may facilitate direct binding to the endothelium (Abranches, Miller et al. 2011, 
Lapirattanakul, Nomura et al. 2013). A large multi-locus typing study of clinical S. mutans 
isolates found the cnm gene primarily in serotype f and k strains, whereas the cbm gene 
was predominately found in serotype k strains (Lapirattanakul, Nomura et al. 2013). Cnm 
and Cbm confer upon S. mutans the ability to adhere to and invade human coronary 
artery and umbilical vein endothelial cells (HUVEC) (Abranches, Miller et al. 2011, 
Nomura, Nakano et al. 2012, Lapirattanakul, Nomura et al. 2013). In addition, S. mutans 
strains expressing Cnm invade non-phagocytic cells, a trait directly related to chronic 
and systemic infections (Aviles-Reyes, Miller et al. 2017). In vitro studies demonstrated 
various levels of collagen binding by S. mutans strains expressing either Cnm or Cbm, 
whereas strains lacking cnm and cbm genes exhibited very low levels of collagen 
binding (Lapirattanakul, Nomura et al. 2013). Compared to cnm-positive strains, cbm-
positive strains demonstrated increased binding to collagen as well as enhanced 
adhesion to, and invasion of, HUVEC (Nomura, Naka et al. 2013). This was supported 
by the increased detection rate of cbm-positive versus cnm-positive strains in heart valve 
tissue from subjects with S. mutans-positive IE (62.5% versus 12.5%). The high rate of 
cbm-positive strains of S. mutans in IE tissues lead to speculation that Cbm may play a 
key role in the pathogenesis of IE (Nomura, Naka et al. 2013). Similarly, S. mutans 
strains expressing CBP are associated with increased risk for cerebrovascular 
dysfunction (hemorrhagic stroke and microbleeds) and ulcerative colitis (Nakano, 
Hokamura et al. 2011, Kojima, Nakano et al. 2012, Miyatani, Kuriyama et al. 2015). 
Given evidence in a variety of other vascular diseases, the CBP of S. mutans may play a 
key role in evolution of atherosclerotic plaques.  
 
NICOTINIC ACETYLCHOLINE RECEPTORS 
The addictive power of nicotine is mediated through neuronal nicotinic 
acetylcholine receptors (nAChR). Nicotine stimulates endothelial and vascular smooth 
muscle cells on the vessel wall through activation of nAChR (Heeschen, Weis et al. 
2002, Lee and Cooke 2011, Lee and Cooke 2012, Cooke 2015). Specifically, nAchRs 
are activated by endogenous acetylcholine or exogeneous nicotine to form ion channels 
in the cell membrane (Lee and Cooke 2011). At clinically relevant concentrations 
nicotine enhances endothelial cell growth, migration and survival – all key processes of 
angiogenesis (Heeschen, Jang et al. 2001, Heeschen, Weis et al. 2002, Heeschen, 
Weis et al. 2003, Cooke 2015). In ApoE-/- mice, clinically relevant doses of nicotine 
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enhanced progression of atherosclerotic plaque and neovascularization (Heeschen, 
Jang et al. 2001). Activation of nAchR in smooth muscle cells results in proliferation and 
migration into the vascular intima where the smooth muscle cells phenotypically change 
to myofibroblasts and osteoblast-like cells that contribute to the extracellular collagen 
matrix and osteopontin in the atherosclerotic plaque (Cooke 2015). Mast cells in the 
aortic adventitia are activated through nAChR leading to degranulation and pro-
inflammatory cytokine production and release, which may be yet another mechanism by 
which nicotine accelerates AT (Wang, Chen et al. 2017).  
The prototypic member of the pentameric ligand-gated ion channel (pLGIC) 
family, nAChR is widely expressed in eukaryotic cells. Prokaryotic homologs of nAChR 
predicted by eukaryotic-prokaryotic genome comparisons have been described in 
several bacterial species including Gloeobacter violaceus  (GLIC), Erwinia chrysanthemi 
and Escherichia coli (Bocquet, Prado de Carvalho et al. 2007, Corringer, Baaden et al. 
2010, Lepore, Indic et al. 2011). Bocquet, et al. suggested in 2007 that the GLIC 
receptor might contribute to bacterial adaptation to pH change, and indeed crystal 
structures reveal that GLIC is an open channel at pH 4 and at pH 7 the proton channel is 
closed (Bocquet, Prado de Carvalho et al. 2007, Cecchini and Changeux 2015). 
Although not specifically studied in S. mutans and other oral bacteria, one might 
speculate that similar prokaryotic pLGIC functions allow these species to exist and thrive 
in acidic environments. Taking the speculation further, much as nicotine stimulates 
endothelial and smooth muscle cell proliferation through nAChR, a prokaryotic 
homologue may play a role in nicotine stimulation of biofilm and planktonic proliferation 
in oral bacteria (Figure 2.1). 
 
CONCLUSIONS 
This review revealed how smoking and nicotine alter microbial composition in the 
oral cavity and increase the pathogenicity of several oral microorganisms. Pathological 
interactions between oral microorganisms and human tissues after nicotine exposure are 
associated with multiple oral and systematic diseases. It is important to mention that 
bacterial interaction with other microbial species or human tissues is a complicated 
process. Future studies are needed to demonstrate how the interactions between 
bacterial pathogens and human tissues are affected by nicotine and how these 
interactions alter supra and subgingival bacterial composition. Several studies in this 
review did not discuss or speculate on the mechanism for nicotine to increase biofilm 
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formation. Future studies are needed to define the mechanism(s) by which nicotine 








Table 2.1 Summary of the effects of nicotine and cigarette smoke condensate (CSC) on different species of oral microorganisms. 
 
Study Microorganism Effects of Nicotine/CSC MIC MBIC 
Sayers et al., 1997 
Bagaitkar et al., 2010 
Bagaitkar et al., 2011 
Zeller et al., 2014 
P. gingivalis Synergistic effects between nicotine and bacterial toxins cause 
periodontal disease 
Upregulated FimA upregulation and promoted biofilm formation 
Increased P. gingivalis adherence to Streptococcus gordonii by 
three-fold and promoted biofilm formation 









Huang et al., 2012 
Li et al., 2013 
Li et al., 2014 
Huang et al., 2015 
Li et al., 2016 
S. mutans Enhanced biofilm formation and biofilm metabolic activity 
Increased metabolic activity and sucrose-induced biofilm 
formation 
Enhanced biofilm formation by S. mutans more than S. sanguinis 
Upregulated Gtf and glucan binding protein (GbpA) expression 
Upregulated Idh, nlmC and phosphotransferase system (PTS)-











Huang et al., 2014 S. gordonii 
Stimulated planktonic growth, biofilm formation, aggregation and 







Dubois et al., 2014 L. casei Increased total growth and promoted biofilm formation 16 mg/ml 16 mg/ml 
Dubois et al., 2014 A. viscosus Increased total growth and promoted biofilm formation 16 mg/ml 16 mg/ml 
Dubois et al., 2014 R. dentocariosa Increased total growth and promoted biofilm formation 16 mg/ml 16 mg/ml 
Dubois et al., 2014 E. faecalis Increased total growth and promoted biofilm formation 32 mg/ml 16 mg/ml 
Dubois et al., 2014 A. naeslundii Decreased total growth and biofilm formation 16 mg/ml 16 mg/ml 
Dubois et al., 2014 C. albicans Increased total growth and promoted biofilm formation 16 mg/ml 16 mg/ml 
 






Figure 2.1 Nicotine has wide-ranging effects on many different eukaryotic cells through 
activation of nicotinic acetylcholine receptors (nAChR).  This figure was designed by A. 
A. Balhaddad and was previously published (Wagenknecht, Balhaddad et al. 2018).  
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Chapter Three 
SURVEY OF THE EFFECTS OF ARGININE AND NICOTINE ON SUCROSE-INDUCED 
BIOFILM DEVELOPMENT OF 33 STRAINS OF S. MUTANS 
INTRODUCTION 
S. mutans, a gram-positive oral bacterium key to development of dental caries, is 
classified by serotype based upon the composition and structure of cell wall 
polysaccharides. Serotypes c, e and f have glucose side chains on a rhamnose 
backbone (Nakano and Ooshima 2009). In contrast, for strains of serotype k there is a 
dearth of glucose side chains on the rhamnose backbone (Nakano, Nomura et al. 2004). 
Serotype c strains of S. mutans are most prevalent. Strains of serotypes f and k 
comprise less than 5% of the S. mutans isolated from the oral cavities of healthy 
individuals, but these serotypes are significantly increased in oral isolates from patients 
with CVD and IE (Nakano, Nemoto et al. 2007, Nakano and Ooshima 2009, Yamamoto 
and Takada 2011). Diseased heart valves and atherosclerotic plaque tissues harbor a 
higher prevalence of serotypes f and k S. mutans strains than the oral cavities of the 
same subjects (Nakano, Nemoto et al. 2007). The presence of the CBP Cbm and Cnm 
has been shown to facilitate S. mutans invasion of endothelial cells and heart valve 
tissues (Nakano, Inaba et al. 2006, Nakano, Nemoto et al. 2007, Nakano, Nemoto et al. 
2009, Abranches, Miller et al. 2011, Aviles-Reyes, Miller et al. 2017). The genes for 
these CBP, cbm and cnm, are found predominantly in S. mutans serotype f and k 
strains.  
Tobacco use is associated with increased risk for CVD and oral diseases, 
including caries (Wagenknecht, Balhaddad et al. 2018). Nicotine, a bioactive agent in 
tobacco, has been shown to increase in vitro growth and metabolism of S. mutans 
serotypes c, e and f strains grown in planktonic and biofilm cultures. Huang et. al. found 
minor enhancement of planktonic growth in seven strains of S. mutans upon addition of 
1 and 2 mg/ml nicotine (Huang, Li et al. 2012). In contrast, biofilm growth of the same 
seven strains increased in a nicotine dose dependent manner until toxicity was reached 
at 16 or 32 mg/ml nicotine depending upon the individual strain. Metabolism of 
established S. mutans biofilm increased, and the cellular morphology changed from the 
usual ellipsoid shape to a more spherical shape with increasing nicotine exposure 
(Huang, Li et al. 2012). Confocal laser scanning microscopy of S. mutans biofilm 
revealed that both bacterial volume and EPS volume were increased in the presence of 
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nicotine (Huang, Li et al. 2015). Nicotine had significant effects on biofilm growth of 
serotype c, e and f strains of S. mutans. The effects of nicotine on serotype k strains of 
S. mutans have not been investigated.  
The basic amino acid, arginine, is present in whole saliva and in ductal saliva 
collected from parotid glands (Van Wuyckhuyse, Perinpanayagam et al. 1995, Sharma, 
Lavender et al. 2014). The concentration of arginine in parotid saliva is increased in 
caries-free compared to caries-susceptible individuals, suggesting that arginine plays a 
role in the control of caries development (Van Wuyckhuyse, Perinpanayagam et al. 
1995). Free arginine is also found in the endothelial glycocalyx of endothelium at the site 
of S. mutans invasion into cardiovascular tissues (Tarbell and Pahakis 2006, Flam, 
Eichler et al. 2007). In vitro studies have demonstrated that the adhesive and structural 
properties of S. mutans biofilm are altered in the presence of arginine compared to 
biofilm grown without supplemental arginine. By using atomic force microscopy, Sharma 
et. al. demonstrated that both adhesion force and rupture length for S. mutans biofilms 
were decreased with addition of arginine in a dose dependent manner, leaving the 
biofilm with a more fragile structure (Sharma, Lavender et al. 2014). In vitro studies of 
serotype c strains demonstrated that arginine increased biomass and decreased 
extracellular polysaccharides (EPS) compared to S. mutans biofilm cultured in the 
absence of arginine (Zheng, Cheng et al. 2015). Other studies demonstrated that 
arginine causes downregulation of genes encoding virulence factors responsible for 
attachment, competence development and bacteriocin production (Chakraborty and 
Burne 2017). In addition, arginine decreased tolerance to environmental acid and 
oxidative stresses (Chakraborty and Burne 2017). Arginine synergizes with fluoride to 
suppress S. mutans planktonic and biofilm cultures in vitro and increase protection 
against caries lesions in clinical trials of dentifrices (Kraivaphan, Amornchat et al. 2013, 
Zheng, Cheng et al. 2015). Analogous to the alterations of S. mutans biofilm in the 
presence of nicotine, arginine also provokes alterations in S. mutans biofilm production.  
Studies of the effects of nicotine and arginine on S. mutans biofilm have been 
carried out with serotype c, e and f strains of S. mutans. The serotype k strains of S. 
mutans are more prevalent in the oral cavities of CVD patients compared to healthy 
subjects and are predominant in diseased CV tissue. Most studies of the effects of 
nicotine and arginine have been carried out with single reference strains. No published 
studies have included serotype k strains or strains which have been typed for CBP. I 
investigated the effects of arginine and nicotine, separately and in combination, on 
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biofilm growth and structure using a large panel of serotyped and CBP genotyped strains 
of S. mutans.  
 
MATERIALS AND METHODS 
Bacterial strains and growth conditions 
S. mutans strains used in this study are listed in Table 3.1. The serotyped and 
genotyped strains were kind gifts of Drs. Noel Childers and Stephanie Momeni at 
University of Alabama School of Dentistry; Dr. Kazuhiko Nakano, Osaka University 
Graduate School of Dentistry, Osaka, Japan and Kazuko Takada, Nihon University 
School of Dentistry at Matsudo, Chiba, Japan. Frozen stock of each strain was 
inoculated into TSB (Becton, Dickinson and Co., Sparks, MD, USA), and then incubated 




Experiments were performed in 96-well microtiter plates using TSB with 1% 
sucrose (TSBS) to promote biofilm formation. A stock solution of TSBS containing 200 
mg/ml arginine (Sigma-Aldrich, St. Louis, MO, USA) in TSB with 1% sucrose (TSBS) 
was adjusted to the pH of TSBS (pH 7.2) prior to sterilization. TSBS was used to dilute 
the stock arginine-TSBS to the desired concentration. Nicotine (Sigma-Aldrich) was 
added to TSBS immediately prior to each experiment. Briefly, 100 µl of TSBS without or 
with double the desired concentration of nicotine and/or arginine was added to 
quadruplicate wells of a 96-well microtiter plate. Next, 100 µl of overnight S. mutans 
culture diluted 1:50 in TSBS (106 S. mutans cells) was added to each well, resulting in 
the stated final concentrations of nicotine and arginine. Biofilms were grown separately 
in nicotine and arginine, in the absence of either and in the presence of both and in 
quadruplicate wells for each treatment. The microtiter plates were incubated for 24 hours 
at 37oC in 5% CO2. Each experiment was repeated three times.  
 
Crystal violet assay 
In order to assess biofilm mass after 24-hours, the biofilm was stained with 
crystal violet. Briefly, after removing the growth media, each biofilm was washed three 
times with sterile distilled H2O (dH2O); the plates were then blotted on absorbent paper 
prior to 30-minute room temperature incubation with 10% formaldehyde (Sigma-Aldrich). 
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After three additional dH2O washes, a 0.5% crystal violet solution (Sigma-Aldrich) was 
placed on the biofilm for 30 minutes followed by additional dH2O washes to remove 
excess crystal violet. Next, 2-propanol was added for 60 minutes to extract the crystal 
violet from the bacterial cells prior to reading the optical density of each well at 490 nm 
on a SpectraMax Plus spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). 
 
XTT assay 
S. mutans cellular metabolism within the biofilm was measured by a 2, 3-bis (2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide 
(XTT) reduction assay as previously described (Huang, Li et al. 2012). Briefly, the biofilm 
was washed three times with sterile 0.9% NaCl (Sigma-Aldrich) prior to reaction with 0.2 
mg/ml XTT salt (Sigma-Aldrich) in 10% ethanol with 3 µg/ml menadione (Sigma-Aldrich) 
for 2 hours at 37oC in the dark. After the incubation, the XTT solution from each well was 
transferred to the same relative well in a fresh microtiter plate, and the optical density at 
490 nm was read in a spectrophotometer. 
 
Confocal laser scanning microscopy (CLSM) 
Biofilm was grown directly on 8-chamber cover glasses (Nunc Lab-Tek™II, 
ThermoFisher Scientific, Waltham, MA, USA) according to the method of Huang, Li et al. 
(Huang, Li et al. 2012) by inoculating 18-hour planktonic cultures into TSBS containing 
the appropriate additive and 1.0 µM Alexa Fluor 568 labeled dextran (ThermoFisher 
Scientific), to label developing EPS. The biofilms were incubated at 37oC in 5% CO2 for 
24-hours, and then washed 3 times with sterile dH2O. Next, bacterial cells within the 
biofilm were stained with Syto9 (1:5000, ThermoFisher Scientific) for 15 minutes in the 
dark at room temperature before three additional washes with sterile dH2O. After the 
final wash, the biofilms were air-dried, then covered with Prolong™ Gold Antifade 
Mountant (ThermoFisher Scientific). Fluorescent images were obtained by using an 
Olympus FV1000 MPE confocal laser scanning microscope with Olympus FV10-ASW 
software (Olympus Corp., Center Valley, PA, USA) at the Indiana Center for Biological 
Microscopy, Indiana University School of Medicine. Full-depth Z-stacks were collected 
from at least three distinct fields from each cover glass grown biofilm. Up to 7 fields per 
biofilm were collected when inspection through the CLSM revealed visually distinct 
regions within a biofilm. All Z-stacks from the total depth of each biofilm field were 
processed. The total volumes of EPS (red, Alexa Fluor 568) and bacteria (green, Syto9) 
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in the processed images were analyzed by Imaris Image Analysis Software version 8 
(Bitplane, South Windsor, CT, USA), and the volumes of EPS and bacteria were 
expressed in pixels. 
 
Statistical analyses 
Each crystal violet and XTT experiment was performed in quadruplicate 
microtiter wells and independently repeated three times. For the CLSM experiments, a 
minimum of three separate microscopic fields were collected for each strain and 
treatment combination. Z-stacks were collected from the full-thickness observed in each 
field from the first visible fluorescence on the surface of the cover glass to the last visible 
fluorescence at the top of the biofilm. Two-way ANOVA with interaction and random 
effect for multiple measures was used for statistical analyses. When non-normality was 
present, a rank transformation was performed prior to the analysis. 
 
RESULTS 
Titration of nicotine and arginine in biofilm growth media 
Working under the observation that serotype k strains of S. mutans differ from 
serotype c strains in terms of prevalence in the oral cavity and in association with extra-
oral tissue infection, I selected 10 strains of each serotype to determine whether 
serotype influenced biofilm growth. In previous studies, nicotine enhanced S. mutans 
biofilm growth. Variability was found among the strains; however, biofilm growth peaked 
between 4 and 8 mg/ml nicotine for serotype c, e and f strains (Huang, Li et al. 2012, 
Huang, Li et al. 2015). Previous studies from my lab showed that the metabolic activity 
of S. mutans biofilm decreased with 16 mg/ml and was absent at 32 mg/ml nicotine 
(Huang, Li et al. 2012). Nicotine dose titration curves of the 20 selected strains were 
consistent with published data (Figure 3.1). Based upon these experiments, doses of 0 
and 4 mg/ml of nicotine were selected for the present study of biofilm growth.  
In order to determine the arginine concentration for subsequent studies, a dose 
titration was performed for the same 20 strains (Figure 3.2). There was no difference in 
biofilm mass between 0 and 5 mg/ml arginine doses measured by crystal violet staining 
(p=0.9325). Compared to biofilm grown without arginine, increases in biofilm mass 
occurred in the presence of 10 mg/ml and 20 mg/ml arginine (p=0.0339 & 0.0253, 
respectively). Biofilm grown in 10 mg/ml arginine was not different from 20 mg/ml 
arginine (p=0.9078). Doses of 40 and 80 mg/ml arginine resulted in significant 
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decreases in biofilm mass compared to baseline (p<0.001). Similarly, bacterial 
metabolism measured by the XTT assay was increased by doses of 10 and 20 mg/ml 
arginine (p=0.0133 and 0.0054, respectively) and decreased by 40 and 80 mg/ml doses 
(p=0.0016 and <0.0000). When analyzed individually, several strains displayed lower 
biofilm mass and metabolism with 20 mg/ml than with 10 mg/ml arginine. Collectively, 
these observations lead us to select 10 mg/ml arginine for subsequent experiments. 
 
Effects of arginine and nicotine on S. mutans biofilm 
The effects of nicotine and arginine, separately and in combination, were 
assessed in parallel biofilm experiments with 10 strains of serotype c and 23 serotype k 
strains. Biofilm grown in TSBS served as the biofilm baseline control for the same strain 
grown concurrently in 10 mg/ml arginine, 4 mg/ml nicotine, or 10 mg/ml arginine plus 4 
mg/ml nicotine. Each biofilm was grown in quadruplicate wells and in three separate 
experiments. Figure 3.3 summarizes the biofilm biomass measured by crystal violet 
staining and metabolic activity measured by XTT for the 33 strains. Biofilm grown in 10 
mg/ml arginine was not different from biofilm grown in TSBS alone. Addition of 4 mg/ml 
nicotine significantly increased the biomass and metabolic activity of 24-hour S. mutans 
biofilm (p<0.0001). Similarly, the combination of nicotine and arginine increased S. 
mutans biofilm mass and metabolic activity compared to nicotine alone (p=0.0028 and 
0.0021, respectively).  
When analyzed by serotype, neither the biomass nor metabolic activity was 
significantly different between serotypes c and k across all treatments (p=0.6093 and 
0.2650, respectively). Individual treatments did not affect the biomass of serotype c 
strains differently than serotype k strains as shown in Table 3.2. Biofilm from serotype k 
strains was not significantly different from that produced by serotype c strains regardless 
of treatment group. 
We next asked whether CBP genotype influenced biofilm biomass or metabolic 
activity. The CBP genotype was known for 30 of the 33 strains tested; 13 strains were 
cbm+/cnm-, seven were cbm-/cnm+, three had both genes and seven strains had 
neither gene. The biomass of cbm-/cnm+ strains was significantly increased compared 
to strains lacking CBP genes, cbm-/cnm- (p=0.0032, Table 3.3 and Figure 3.4). The 
cbm+/cnm- strains showed a non-significant increase in biomass compared to cbm-
/cnm- and cbm+/cnm+ strains. Compared to TSBS, arginine had a significant effect only 
on cbm+/cnm- strains which demonstrated decreased biomass. In contrast, nicotine 
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significantly increased the biomass of cbm+/cnm-, cbm-/cnm+ and cbm-/cnm- stains. A 
modest, non-significant increase was seen when nicotine was added to the cultures of 
strains with both CBP. Strains with the both genes demonstrated increased biomass 
when arginine was added to the nicotine (p=0.0001).  
Table 3.4 displays the metabolic activity data. When grown in TSBS, the 
metabolic activity of cbm-/cnm+ strains was not significantly different from that of the 
cbm+/cnm- strains (p=0.1702) but was increased compared to strains lacking CPB 
(p<0.0001) and cbm+/cnm+ strains (p=0.0040). In general, neither arginine nor nicotine 
altered the aforementioned observations. When arginine and nicotine were combined, 
the metabolic activity of cbm-/cnm+ strains was increased compared to cbm+/cnm- 
strains (p=0.0172) and even more so compared to cbm-/cnm- and cbm+/cnm+ strains 
(p<0.0001 and =0.0032, respectively). 
 
Confocal laser scanning microscopy for measurement of bacteria and EPS in biofilm 
Crystal violet stains the bacterial cells as well as the EPS produced by the S. 
mutans during biofilm formation. By comparison, the XTT assay detects metabolic 
activity of S. mutans, and the amount of EPS production is not directly measured in this 
assay. I therefore used CLSM to separately measure S. mutans nucleic acid (Syto9, 
green) and EPS (Alexa Fluor 568, red) in the biofilm. Images of the full biofilm thickness 
were analyzed with Imaris image analysis software to create full-depth three-dimensional 
images of the biofilm in order to separately quantitate the amount of S. mutans and EPS 
in each field. Six strains representing serotype c (n=3) and k (n=3) and three CBP 
genotypes cbm-/cnm- (n=3), cbm+/cnm- (n=2) and cbm-/cnm+ (n=1) were selected for 
CLSM analyses (see Table 3.1). Representative images of single CLSM fields are 
shown in Figure 3.5. In most images, S. mutans and EPS were found interspersed 
throughout the biofilm. Images of strain 219-1-PP30-07-07 contained towers of S. 
mutans with little to no EPS visible within the towers. Analyses of the red and green 
pixels in each image revealed that neither serotype nor genotype had a significant effect 
on the amount of S. mutans in the 24-hour biofilms (p=0.8325 and 0.3391, respectively). 
In contrast, the effects of serotype and genotype on EPS production were significant 
(p=0.0145 and <0.0001, respectively). As shown in Table 3.5, the cbm-/cnm+ strain 
produced significantly more EPS than the cbm+/cnm- and cbm-/cnm- strains (p<0.0001 
and <0.0001). The serotype c strains produced significantly more EPS than the serotype 
k strains (p=0.0145); however, this observation is confounded because the single cnm 
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positive strain studied by CLSM is serotype c. The amount of EPS produced by the 
strains lacking the cnm gene was not different for strains with or without the cbm gene 
(p=0.9396).  
CLSM analyses revealed that treatment of the biofilm with arginine and nicotine 
had significant effects on both S. mutans (p=0.0069) and EPS production (p=0.0032). 
Addition of 4 mg/ml nicotine to TSBS resulted in increased volume of S. mutans 
compared to biofilm grown in TSBS alone and arginine supplemented media with or 
without nicotine (Figure 3.6A). Addition of arginine to nicotine decreased S. mutans 
bacterial cell volume compared to nicotine alone (p=0.0404, Table 3.6) and was not 
significantly different from biofilm grown in TSBS or arginine only. Similarly, nicotine 
increased EPS production but addition of arginine with nicotine decreased EPS 
(p=0.0006). In order to assess the combined effects on S. mutans volume and EPS 
production, the ratio of EPS to S. mutans was evaluated for each genotype and 
treatment (Figure 3.6B). The ratio of EPS to S. mutans volume was increased for the 
strain with the cnm gene compared to strains with cbm and those lacking both genes. 
Addition of nicotine, arginine, or the combination to TSBS decreased the EPS:S. mutans 
volume ratio significantly indicating that the bacterial volume increased disproportionally 
to EPS production in the presence of nicotine and/or arginine. 
 
DISCUSSION 
Previous studies have reported that compared to serotype c strains of S. mutans, 
serotype k strains produce less glucose-induced acid, and demonstrate low levels of 
sucrose-dependent adhesion and dextran-binding activity (Lapirattanakul, Nakano et al. 
2009, Yamamoto and Takada 2011). Additionally, serotype k strains are less susceptible 
to phagocytosis by human polymorphonuclear leukocytes, which may explain the 
increased prevalence of serotype k strains in infected mammalian soft tissues 
(Lapirattanakul, Nakano et al. 2009). I report a large survey of the biofilm growth 
characteristics of S. mutans serotype k strains in comparison to S. mutans serotype c 
strains. There was an insignificant increase in biomass of S. mutans serotype c strains 
compared to serotype k strains when grown in TSBS alone. In contrast, the metabolic 
activity of the serotype k strains was increased compared to the serotype c strains 
studied but this also was not significant. CLSM analyses of 3 strains of each serotype 
did not reveal statistical differences between the serotypes for volume of either bacterial 
cells or EPS. These observations expand on an earlier study of serotype k strains NUM-
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Smk-51, NUM-Smk52 and NUM-Smk89, which were also used in the present study, 
wherein sucrose-induced glucan synthesis and dental plaque formation by these three 
serotype k strains were similar to serotype c strains (Yamamoto and Takada 2011). 
Yamamoto and Takada reported lower acid production in the presence of glucose by 
these serotype k strains compared to serotype c strains, which may relate to the idea 
that serotype k strains are less cariogenic than serotype c strains. The serotype of the S. 
mutans strains used in this study did not have a significant effect on sucrose-induced 
biofilm growth. 
Thirty of the strains were previously genotyped for CBP genes allowing analysis 
of the effects of the cbm and cnm genes on development of sucrose-induced biofilm. 
The CBP genotype of the strain had significant effects on biofilm production. When 
grown in TSBS alone, cbm-/cnm+ strains produced significantly more biofilm and 
metabolic activity was increased compared to cbm-/cnm- strains. The cbm+/cnm- strains 
produced moderately increased biofilm, but the metabolic activity of these strains was 
significantly higher than that of the strains lacking both genes. While cbm+/cnm- and 
cbm-/cnm+ strains are not statistically different from each other, there does not appear 
to be a synergistic effect of cbm and cnm on biofilm production as both biomass and 
metabolic activity were decreased for cbm+/cnm+ strains compared to strains 
possessing just one of the CBP genes. In fact, the biomass and metabolic activity of 
cbm+/cnm+ strains were not statistically different from the strains lacking both genes. In 
the CLSM studies, the cbm-/cnm+ strain produced significantly more EPS than the 
cbm+/cnm- and cbm-/cnm- strains. Due to the small number of strains used for the 
CLSM experiments, caution must be used in interpretation of the results; however, data 
are sufficiently intriguing to warrant investigation with additional strains to substantiate 
this observation. 
The addition of 4 mg/ml of nicotine to TSBS significantly increased both the 
biomass and the metabolic activity of S. mutans biofilms. This is the first report of the 
effects of nicotine on serotype k S. mutans, and I report no significant differences in 
biomass, metabolic activity or EPS production compared to serotype c strains upon 
exposure to nicotine. My findings are consistent with previous studies using S. mutans 
serotypes c, e and f, wherein S. mutans biofilm growth and metabolism were increased 
in a nicotine dose dependent manner (Huang, Li et al. 2012, Li, Huang et al. 2013, 
Huang, Li et al. 2015). In the present study, nicotine was added at the beginning of 
biofilm formation, whereas in the 2012 study by Huang et al. nicotine was added to 
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established 24-hour S. mutans biofilms, and the metabolic activity was measured 24 
hours later. Given that similar nicotine dose response profiles were reported for nascent 
and established biofilm, comparatively these studies indicate that nicotine can increase 
S. mutans biofilm growth regardless of when nicotine exposure occurs.  
The CLSM studies with six S. mutans stains revealed that 4 mg/ml nicotine 
increased S. mutans bacterial volume. My findings are supported by previous studies of 
S. mutans UA159 (serotype c) biofilm, which reported increased bacterial volume with 
nicotine doses of 2 and 4 mg/ml in single- and dual-species biofilms (Li, Huang et al. 
2014, Huang, Li et al. 2015). In studies of cigarette smoke exposure, another S. mutans 
strain (ATCC 25175) displayed increased colony size as the nicotine content of the 
cigarette increased (Zonuz, Rahmati et al. 2008). Zonuz, et al. reported a 51% greater 
increase in S. mutans colony size compared to Streptococcus sanguinis. In this study of 
6 strains, nicotine alone did not have a significant effect on EPS production (p=0.3669), 
whereas other single- and dual-species biofilm studies found increased EPS production 
in the presence of nicotine. Single-species studies of sucrose-induced UA159 biofilm 
found that the EPS volume was significantly increased by addition of 2 and 4 mg/ml 
nicotine (Huang, Li et al. 2015). In dual-species biofilm with S. sanguinis, EPS 
production by UA159 in 2 mg/ml nicotine was significantly increased compared to biofilm 
grown without nicotine (Li, Huang et al. 2014). In both studies, only UA159 was 
investigated. My data suggest that increased EPS production in the presence of nicotine 
may be a characteristic of UA159 and may not be attributable to all strains of S. mutans.   
Overall, addition of 10 mg/ml arginine to sucrose-induced biofilm had no effect on 
the metabolic activity of S. mutans biofilm. Collectively, the biomass was unchanged by 
addition of 10 mg/ml arginine for the strains investigated. In contrast, cbm+/cnm- strains 
produced significantly less biomass in the presence of 10 mg/ml arginine compared to 
TSBS alone. Significantly more biomass was produced by cbm-/cnm+ strains than 
cbm+/cnm- and cbm-/cnm- genotypes in the presence of arginine. The metabolic 
activities of the cbm-/cnm+ strains were greater than those of the strains lacking both 
genes but were not statistically different from cbm+/cnm- strains. CLSM studies showed 
that strains with a CBP gene treated with arginine had greater proliferation. In contrast, 
EPS production was decreased by addition of arginine. There was no significant change 
in either S. mutans or EPS volume in the presence of arginine; however, the EPS:S. 
mutans bacteria ratios were significantly lower when compared to biofilm grown in TSBS 
alone indicating a decrease in EPS relative to S. mutans volume. These data are 
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consistent with previous studies of single type strains of S. mutans,, which have shown 
that addition of arginine results in increased biomass with decreased EPS production 
(UA159) and a more fragile sucrose-induced S. mutans biofilm (UA140) compared to 
biofilm grown in the absence of arginine (Sharma, Lavender et al. 2014, Zheng, Cheng 
et al. 2015, He, Hwang et al. 2016, Huang, Zhang et al. 2017). Using two different 
nutrient-rich media, Chakraborty and Burne demonstrated that 1.5% arginine induced 
decreases in overall biofilm production and differences in UA159 growth curves 
(Chakraborty and Burne 2017). The relative amount of L-arginine and the growth media 
used in these experiments vary thereby demonstrating that the effect of arginine is not 
dependent upon the specific growth media and that arginine exerts its effect over a 
range of concentrations (0.5 to 10%). 
Nicotine upregulates S. mutans UA159 virulence genes, glucosyltransferases, 
glucan binding proteins and bacteriocin production (Huang, Li et al. 2015, Li, Huang et 
al. 2016, Liu, Qiu et al. 2017) (Shepherd et al., unpublished). S. mutans antigen I/II was 
upregulated in strain NG8 biofilm in the presence of nicotine (Li, Huang et al. 2013). In 
contrast, Chakraborty and Burne demonstrated that arginine downregulates genes 
encoding virulence factors responsible for attachment, competence development and 
bacteriocin production (Chakraborty and Burne 2017). S. mutans displayed lower 
tolerance to environmental acid and oxidative stress in the presence of arginine 
(Chakraborty and Burne 2017). Because nicotine and arginine exert opposite effects on 
S. mutans UA159, I investigated the combined effects on biofilm production by UA159 
and 32 additional strains of S. mutans. My results support published observations in that 
nicotine enhanced biofilm production and arginine decreased biofilm. Furthermore, 
combined arginine and nicotine enhanced biomass and metabolic activities compared to 
nicotine alone as shown by the crystal violet and XTT experiments. The CLSM 
experiments with a limited number of strains demonstrated that addition of arginine to 
nicotine resulted in significantly decreased volume of S. mutans for the cbm+/cnm- 
strains and decreased EPS volume for all strains compared to biofilm grown with 
nicotine alone. These data indicate that arginine diminishes nicotine enhanced EPS 
production. The nicotine enhanced S. mutans bacterial growth of strains bearing the cbm 
gene was reduced by adding arginine to nicotine. Additional studies are required to 
determine the mechanism(s) by which arginine reduces nicotine increased EPS 
production; however, one might speculate that arginine acts upon regulatory processes 
or upstream of the point of nicotine interaction with genes that control EPS production.  
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Two clinical studies found that tobacco smokers do not have increased S. 
mutans in saliva compared to non-smokers (Sheth, Makda et al. 2016, Nakonieczna-
Rudnicka and Bachanek 2017). These studies did not type for CBP in oral isolates. I 
found nicotine enhanced biofilm production for all strains. The biofilm metabolic activities 
for strains bearing cbm and cnm genes were increased compared to strains without 
genes for CBP. Previous studies have shown that the cnm gene contributes to oral 
colonization by S. mutans, and is a predictor of development and severity of dental 
caries lesions (Nomura, Nakano et al. 2009, Miller, Aviles-Reyes et al. 2015, Esberg, 
Sheng et al. 2017). The cbm gene has 78% identity with the cnm gene, and cbm+ 
strains exhibit greater collagen binding activity than strains bearing the cnm gene 
(Nomura, Nakano et al. 2012). There is controversy over the relationship between the 
two genes, which have been reported to be located within the same locus, whereas 
others have reported multiple strains bearing both genes simultaneously (Aviles-Reyes, 
Miller et al. 2017, Momeni, Ghazal et al. 2019). My data from multiple strains indicate 
similarities between cbm and cnm in biomass and metabolic activities for strains with 
either gene. Strains bearing both genes do not demonstrate synergistic effects of the 
genes and were found to have lower responses to nicotine than strains with either gene 
alone. These observations are indicative of cbm and cnm being separate genes with 
significant sequence identity. 
In conclusion, serotype c and serotype k strains are not significantly different in 
terms of biofilm production or responses to nicotine and arginine. The presence of cbm 
and cnm affected biofilm growth and responses to nicotine such that strains with a CBP 
produced more biomass and were more metabolically active. Addition of nicotine 
resulted in increased biofilm for all strains. Arginine added with nicotine reduced the 
quantity of bacteria and EPS in the biofilm. In as much as arginine has been added to 
fluoride in dentifrices, this combination may be especially beneficial for tobacco users 
due to the ability of arginine to reduce nicotine induced EPS production. 
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Table 3.1  S. mutans strains used in this Chapter.  
        
Strain  Serotype  cbm  cnm   Source 




k  -  - 
 
S. Momeni, N. Childers 
505-1-PBB-05-06 
 
k  -  - 
 
S. Momeni, N. Childers 
548-1-PBT-05-04* 
 
k  +  - 
 
S. Momeni, N. Childers 
573-1-PBS-05-03 
 
k  -  - 
 
S. Momeni, N. Childers 
578-1-PBB-06-01 
 
k  +  - 
 
S. Momeni, N. Childers 
608-1-PBB-06-03 
 
k  +  - 
 
S. Momeni, N. Childers 
AT1 
 




















k  +  - 
 
K. Nakano 
NUM-Smk51  k  n/a
3 
 n/a  K. Takada
4 
NUM-Smk52  k  n/a  n/a  K. Takada 
NUM-Smk89  k  n/a  n/a  K. Takada 
OR22P1 k  -  + K. Nakano 
SA31 
 



































c  +  - 
 
S. Momeni, N. Childers 
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Table 3.2  The effects of S. mutans serotype on biofilm responses to arginine (10 mg/ml) and nicotine (4 mg/ml). 
     Serotype   
     c  k   
      OD 490nm  OD 490nm   
  
Arginine 
(10 mg/ml)  
Nicotine 
(4 mg/ml)  mean  SD  mean  SD  P-value 
               
Crystal Violet – Biofilm Mass 
  
  -  -  0.717  0.217  0.671  0.225  0.1987 
  +  -  0.689  0.198  0.628  0.209  0.1127 
  -  +  0.938  0.308  1.019  0.397  0.6341 
  +  +  0.930  0.363  1.066  0.463  0.1884 
               
XTT – Biofilm Metabolic Activity                     
  -  -  0.461  0.144  0.518  0.291  0.2479 
  +  -  0.464  0.131  0.508  0.297  0.2836 
  -  +  0.542  0.159  0.657  0.372  0.2308 








Table 3.3  The effects of S. mutans CBP genotype on biofilm mass measured by crystal violet in response to 10 mg/ml arginine and 





















Arginine Nicotine mean SD p p p p p p 
  
cbm-/cnm- (7)       
- - 0.606 0.212 0.4014 0.0000 0.0000 0.6737 0.0666 0.0032 
+ - 0.584 0.228  0.0000 0.0000 0.3106 0.3165 0.0070 
- + 0.872 0.388   0.7210 0.1125 0.016 0.0000 
+ + 0.862 0.365    0.9594 0.1026 0.0000 
  
cbm+/cnm+ (3)       
- - 0.626 0.259 0.4596 0.1876 0.0000  0.3535 0.0554 
+ - 0.661 0.206  0.2028 0.0000  0.7251 0.2650 
- + 0.688 0.309   0.0001  0.0004 0.0000 
+ + 0.837 0.285     0.2379 0.0006 
  
cbm+/cnm- (13)       
- - 0.712 0.233 0.0001 0.0000 0.0000   0.1204 
+ - 0.647 0.201  0.0000 0.0000   0.0340 
- + 1.029 0.344   0.0481   0.0167 
+ + 1.020 0.440      0.0006 
  
cbm-/cnm+ (7)       
- - 0.777 0.133 0.1199 0.0000 0.0000    
+ - 0.746 0.181  0.0000 0.0000    
- + 1.190 0.243   0.3527    






Table 3.4 The effects of S. mutans CBP genotype on biofilm metabolic activity in response to 10 mg/ml arginine and 4 mg/ml 
nicotine.  
Arginine Nicotine 



















  mean SD p p p p p p 
  cbm-/cnm- (7)        
- - 0.355 0.267 0.2801 0.0008 0.0000 0.5376 0.0002 0.0000 
+ - 0.341 0.257  0.0000 0.0000 0.2480 0.0001 0.0000 
- + 0.419 0.34   0.5754 0.1894 0.0000 0.0000 
+ + 0.43 0.347       0.0708 0.0000 0.0000 
  cbm+/cnm+ (3)        
- - 0.419 0.144 0.1775 0.0000 0.0000  0.0359 0.0040 
+ - 0.464 0.095  0.0000 0.0000  0.1080 0.0172 
- + 0.517 0.119   0.0023  0.0214 0.0022 
+ + 0.572 0.113         0.1518 0.0032 
  cbm+/cnm- (13)        
- - 0.593 0.232 0.4294 0.0000 0.0000   0.1702 
+ - 0.573 0.194  0.0000 0.0000   0.1894 
- + 0.745 0.282   0.9997   0.1742 
+ + 0.745 0.285           0.0172 
  cbm-/cnm+ (7)        
- - 0.654 0.136 0.4162 0.0000 0.0000    
+ - 0.65 0.156  0.0000 0.0000    
- + 0.814 0.206   0.0001    
+ + 0.914 0.205             
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Table 3.5  Pairwise comparisons of the effects of genotype on S. mutans, EPS and 
EPS:S. mutans ratio in biofilm as measured by CLSM. 
 





     
S. mutans     
 cbm+/cnm-  cnm-/cnm+ n.s. 
 cbm+/cnm-  cbm-/cnm- n.s. 
 cnm-/cnm+  cbm-/cnm- n.s. 
     
EPS     
 cbm+/cnm- < cnm-/cnm+ <0.0001 
 cbm+/cnm-  cbm-/cnm- 0.9396 
 cnm-/cnm+ > cbm-/cnm- <0.0001 
     
EPS : S. mutans     
 cbm+/cnm- < cnm-/cnm+ 0.0001 
 cbm+/cnm-  cbm-/cnm- 0.4316 
 cnm-/cnm+ > cbm-/cnm- <0.0001 
 




Table 3.6  Pairwise comparisons of the effects of treatment on S. mutans, EPS and 
EPS:S. mutans ratio in biofilm as measured by CLSM. 
  Direction 
of effect 
 p-value 
S. mutans    
 TSBS  arginine 0.2437 
 TSBS < nicotine 0.0007 
 TSBS  arginine + nicotine 0.1748 
 arginine < nicotine 0.0202 
 arginine  arginine + nicotine 0.8213 
 nicotine > arginine + nicotine 0.0404 
     
EPS    
 TSBS  arginine 0.1374 
 TSBS  nicotine 0.3669 
 TSBS > arginine + nicotine 0.0061 
 arginine < nicotine 0.0227 
 arginine  arginine + nicotine 0.1783 
 nicotine > arginine + nicotine 0.0006 
     
EPS : S. mutans    
 TSBS > arginine 0.0022 
 TSBS > nicotine 0.0332 
 TSBS > arginine + nicotine 0.0001 
 arginine  nicotine 0.3356 
 arginine  arginine + nicotine 0.3469 









Figure 3.1  Effects of nicotine on S. mutans biofilm formation. Nicotine was added to 
TSBS in doubling doses from 0.25 to 16.0 mg/ml prior to addition of S. mutans into 
quadruplicate wells of a 96-well plate and incubation at 37oC, 5% CO2 for 24 hours. The 
24-hour biofilm from 10 serotype k (A) and 10 serotype c (B) strains was stained with 
crystal violet. The mean absorbance for each dose is shown. The error bars represent 
the standard deviation of quadruplicates. The bars with diagonal lines represent TSBS 
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Figure 3.2  Selected strains of S. mutans serotypes k and c biofilm in studies of dose 
response to arginine. Biomass of serotype k (A) and c (B) strains stained with crystal 
































































































Figure 3.3  Bar and whiskers graphs showing the effects of arginine and nicotine on S. 
mutans 24-hour biofilm growth and metabolic activity. Biofilm from all 33 strains was 
grown for 24-hours in TSBS (dark gray), 10 mg/ml arginine (black and white diagonal), 4 
mg/ml nicotine (light gray ), or 10 mg/ml arginine plus 4 mg/ml nicotine (gray and black 
diagonal) and then (A) stained with crystal violet to measure biomass or (B) tested for 
metabolic activity by the XTT assay. Statistical differences are shown in (C). Each data 





10 mg/ml arginine 4 mg/ml nicotine 10 mg/ml arginine + 4 mg/ml nicotine
p p p
Biomass
TSBS 0.0561 0.0000 0.0000
10 mg/ml arginine 0.0000 0.0000
4 mg/ml nicotine 0.0028
Metabolic Activity
TSBS 0.6107 0.0000 0.0000
10 mg/ml arginine 0.0000 0.0000




Figure 3.4  Effects of S. mutans genotype on biofilm production in the presence of 
arginine (10 mg/ml), nicotine (4 mg/ml), and arginine plus nicotine. Arginine and nicotine 
were added separately and together to TSBS prior to addition of S. mutans cultures into 
quadruplicate wells of a 96-well plate and incubation at 37oC, 5% CO2 for 24 hours. The 
24-hour biofilm was stained with crystal violet (A) to determine biomass, and the XTT 
reduction assay (B) was performed to determine metabolic activity of each biofilm. The 
mean absorbance in TSBS is shown by black bars, 10 mg/ml arginine in black and white 
diagonals, 4 mg/ml nicotine in gray, and 10 mg/ml arginine + 4 mg/ml nicotine is shown 
as black diagonals on a gray background. Error bars represent the standard deviation of 

















































S. mutans strain UA159 548-1-PBT-05-04 219-1-PP30-07-07 
Genotype cbm-/cnm- cbm+/cnm- cbm-/cnm+ 
Serotype c k  c 
 
              
          
      
         
Figure 3.5  Representative processed Z-stack images from CLSM analyses of S. mutans 
biofilm grown in TSBS alone, 10 mg/ml arginine, 4 mg/ml nicotine, or 10 mg/ml arginine 
+ 4 mg/ml nicotine. S. mutans bacterial cells are labeled green with Syto9 and the EPS 
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Figure 3.6  S. mutans bacterial cells and EPS from 24-hour biofilm measured by CLSM. 
The effects of 10 mg/ml arginine, 4 mg/ml nicotine and the combination on S. mutans 
biofilm were quantified by CLSM. Alexa Fluor 568 labeled dextrans were added at the 
beginning of biofilm formation to label the EPS as it was synthesized. Arginine and 
nicotine were added simultaneously with the Alexa Fluor 568 labeled dextrans. Prior to 
imaging the 24-hour biofilm, S. mutans DNA was labeled with Syto 9. Biofilm grown in 
TSBS alone (black) was compared to biofilm grown with 10 mg/ml arginine (black and 
white diagonal), 4 mg/ml nicotine (gray), and 10 mg/ml arginine plus 4 mg/ml nicotine 
(black and gray diagonal). (A) Total pixels representing bacterial cells and EPS for each 
CBP genotype of S. mutans tested by CLSM. (B) Ratio of EPS to S. mutans bacterial 
cells. (C) Crystal violet and XTT analyses of the specific subset of strains used in the 
CLSM experiments. Each bar represents analyses of 3 to 7 fields from each biofilm and 
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ENDOTHELIAL CELL INVASION BY S. MUTANS GROWING IN PLANKTONIC 
CULTURE 
INTRODUCTION 
S. mutans, a native resident of oral plaque, is the causative agent of dental 
caries. Carbohydrate fermentation by S. mutans within the oral plaque creates an acidic 
environment at the tooth surface causing demineralization and erosion of dental hard 
tissues. When it escapes the oral cavity, S. mutans can cause bacteremia and invade 
extra-oral soft tissue leading to IE, atherosclerotic plaques and cerebrovascular stroke 
(Nomura, Nakano et al. 2006, Nakano, Nemoto et al. 2009, Nakano and Ooshima 2009, 
Nomura, Naka et al. 2013, Miyatani, Kuriyama et al. 2015, Inenaga, Hokamura et al. 
2018).  
Strains of S. mutans are defined by serotype c, e, f or k according to the structure 
of cell surface polysaccharides that are comprised of a rhamnose backbone with glucose 
side chains. The ratio of glucose to rhamnose is drastically decreased in serotype k 
strains, which may contribute to the increased infectivity of serotype k strains (Nakano 
and Ooshima 2009). In the oral cavity, more than 70% of S. mutans strains are of 
serotype c, serotype e strains represent approximately 20%, and the frequencies of 
serotypes f and k are less than 5% of oral S. mutans (Nakano, Nemoto et al. 2007, 
Nomura, Nakano et al. 2012). Serotype k strains represent roughly 1.5% of the S. 
mutans isolated from the oral cavities of healthy subjects; however, within the oral 
cavities of patients with CVD, 10.3% of S. mutans strains were found to be serotype k 
(p<0.05) (Nakano, Nemoto et al. 2007). In addition, the oral cavities of patients with CV 
diseases are more likely to harbor S. mutans of multiple serotypes compared to healthy 
subjects (53.8% versus 25.0%, respectively) (Nakano, Nemoto et al. 2007). S. mutans 
serotype k strains were reported in 9.1% of heart valve and 25% of atheromatous tissue 
specimens, and are increased in prevalence in the cardiovascular tissue compared to 
the oral cavities of the same patients (Nakano, Nemoto et al. 2007). These data suggest 
that serotype k strains of S. mutans may adhere to, or interact with, endothelial cells at 
greater frequency than strains of serotype c, the most prevalent serotype in the oral 
cavity.  
Blood isolates of S. mutans serotype k from patients with bacteremia are less 
susceptible to phagocytosis by human polymorphonuclear leukocytes which may explain 
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the longer duration of bacteremia caused by S. mutans serotype k compared to strains 
of other serotypes (Nakano and Ooshima 2009). In vitro studies demonstrated that 
isogenic S. mutans mutants lacking surface antigens were less susceptible to 
phagocytosis than parent strains (Nakano and Ooshima 2009). The diminished presence 
of glucose side chains of serotype k S. mutans may be similar to the isogenic mutants 
lacking surface antigens and enable serotype k strains to evade phagocytosis. Serotype 
k strains may persistent longer in blood than serotype c strains, and this persistence 
may contribute to the increased frequency of serotype k strains in cardiovascular tissue 
compared to oral plaque (Nagata, Okayama et al. 2006, Nakano and Ooshima 2009).  
Expression of CBPs, SpaP (protein antigen I/II, PA I/II), WpaA, Cbm and Cnm on 
the surface of S. mutans impart this bacterium with the ability to interact with the 
extracellular matrix of tissues and organs (Aviles-Reyes, Miller et al. 2017). The CBP 
Cbm and Cnm are produced from the cbm and cnm genes, respectively (Abranches, 
Miller et al. 2011, Nomura, Nakano et al. 2012, Aviles-Reyes, Miller et al. 2017). Studies 
have demonstrated that cbm and cnm confer upon S. mutans the ability to invade non-
phagocytotic mammalian cells leading to chronic and systemic infections (Abranches, 
Zeng et al. 2009, Abranches, Miller et al. 2011, Lapirattanakul, Nakano et al. 2011, 
Nomura, Nakano et al. 2012, Miller, Aviles-Reyes et al. 2015). The cnm gene is present 
in approximately 20% of S. mutans strains but is concentrated in serotype f strains such 
that 80% of serotype f strains bear the gene (Abranches, Miller et al. 2011). In contrast, 
the cbm gene is found in roughly 2% of S. mutans and is usually identified in serotype k 
strains (Aviles-Reyes, Miller et al. 2017). Many studies of endothelial cell invasion have 
focused on S. mutans serotypes e and f strains (Abranches, Zeng et al. 2009, 
Abranches, Miller et al. 2011, Aviles-Reyes, Freires et al. 2018). Studies of endothelial 
cell adhesion and invasion by serotype k strains have been performed with isolates from 
Japan, Finland and Thailand (Nomura, Nakano et al. 2012, Lapirattanakul, Nomura et al. 
2013). To date, no endothelial cell invasion studies have been performed with serotype k 
strains from the United States. 
We investigated the effects of S. mutans CBP genes, cbm and cnm, on 
endothelial cell invasion by 20 serotype k strains of S. mutans in planktonic culture. For 
this, I used cultured bovine aortic endothelial cells (BAEC), which synthesize and 
secrete types III and IV collagen that are immunologically and biochemically analogous 
to basement membrane collagen  (Howard, Macarak et al. 1976, Jaffe, Minick et al. 
1976, Sage, Crouch et al. 1979). The strains represent clinical isolates obtained from 
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pediatric subjects in rural Alabama in the United States as well as previously 
characterized strains from Japan. Serotype c and e strains with and without cbm and 
cnm genes were included in the study  in order to investigate the separate effects of 
serotype and CBP on endothelial cell invasion by S. mutans.  
 
MATERIALS AND METHODS 
Bacterial Strains and Growth Conditions 
S. mutans strains used in this study are listed in Table 4.1. All strains were oral 
isolates of known serotype and cbm/cnm genotype. Most of the strains used in this study 
were kind gifts of Drs. Noel Childers and Stephanie Momeni at University of Alabama 
School of Dentistry and Dr. Kazuhiko Nakano, Department of Pediatric Dentistry, Osaka 
University Graduate School of Dentistry, Osaka, Japan. S. mutans strains OMZ175 and 
UA159 were included as well-characterized control strains. Frozen stock of each strain 
was inoculated into tryptic soy broth (TSB, Becton Dickinson and Co., Sparks, MD, USA) 
and incubated at 37oC in 5% CO2 for 18 to 48 hours prior to each experiment. One ml of 
each overnight culture of S. mutans was washed three times with sterile 0.9% saline and 
resuspended in 1.0 ml of sterile saline. The OD 595nm of each S. mutans strain was 
adjusted to 0.500 +/- 0.150 before diluting 1:100 in BAEC growth media without penicillin 
and streptomycin. The diluted S. mutans cultures were held at 37OC while the 
endothelial cells were washed in preparation for addition of the S. mutans.  
 
BAEC Culture 
BAEC were grown in Dulbecco’s modified Eagle’s medium (DMEM, Corning Life 
Sciences, New York, USA) supplemented with 10% fetal bovine serum (Atlanta 
Biologicals, Flowery Branch, GA, USA),  2 mM L-glutamine (Corning Life Sciences), 100 
IU penicillin (Corning Life Sciences) and 100 ug/ml streptomycin (Corning Life Sciences) 
at 37oC with 5% C02. Cultured BAEC were removed from the surface of the flask by a 
five-minute incubation with 0.25% trypsin protease (Hyclone, GE Healthcare Life 
Sciences, Pittsburgh, PA, USA). After washing the detached cells with DMEM growth 
media, the BAEC were seeded into 24-well plates or into T-75 flasks for further culture. 






BAEC Invasion Assay 
The endothelial cell invasion assay was modified from that developed by 
Abranches et. al. (Abranches, Miller et al. 2011). Briefly, each well of a 24-well plate was 
seeded with 0.5, 1.0 or 2.0 x 105 BAEC in 1.0 ml of BAEC growth media with antibiotics, 
and the plate was incubated for 22 hours at 37OC, 5% CO2. After incubation, the BAEC 
were washed 3 times with warm (37OC) Dulbecco’s phosphate buffered saline (DPBS, 
GE Healthcare, Life Sciences). After discarding the final wash, 1.0 ml of prepared S. 
mutans in BAEC growth media without antibiotics was added to duplicate wells to 
facilitate the attachment and invasion of the bacteria into the BAEC and the plate was 
incubated for 2 hours at 37OC, 5% CO2. During the incubation, each S. mutans inoculum 
was diluted and plated onto blood agar plates in order to determine the number of colony 
forming units (cfu) per ml of inoculum. After the 2-hour incubation, the BAEC were 
washed three times with warm DPBS followed by addition of 1.0 ml of BAEC growth 
medium with antibiotics and incubation at 37OC, 5% CO2 for 2 hours to kill any bacteria 
that attached but did not invade the BAEC. Following the second incubation, the BAEC 
were washed three times with warm DPBS. After discarding the final wash, 1.0 ml of ice-
cold sterile H2O was added to each well of BAEC followed by a 20-minute incubation at 
room temperature to lyse the BAEC. After BAEC lysis, each well was scraped to remove 
BAEC from the plastic surface and the contents of each well was transferred into a 
separate sterile tube. The lysate from each well was plated onto blood agar plates to 
determine the cfu of S. mutans invading the BAEC. For strains with high invasion rates, 
1:10 and 1:100 dilutions of the lysate were required to obtain accurate cfu counts.  
The blood agar plates were incubated at 37OC, 5% CO2 for two days before 
counting cfu to determine the number of S. mutans bacterium in the inoculum and the 
number that invaded the BAEC in each well. The percent of S. mutans invading BAEC in 
each well was calculated as: cfu/ml invading BAEC divided by cfu/ml in the inoculum 




Basic statistics (mean, standard deviation) were computed before statistical 
evaluation by using analyses of ranks and analysis of variance (ANOVA). When non-





Initial invasion assays using 0.5 x 105 BAEC per well in the 24-well plate yielded 
very low to no invasion by the previously untested S. mutans strains from the University 
of Alabama. Since OMZ175 invasion of endothelial cells has been well documented, 
titration experiments of BAEC in 24-well plates were performed with OMZ175 prior to 
continuing the BAEC invasion assays with the untested strains. To do this, BAEC diluted 
to 0.5 x 105, 1.0 x 105and 2.0 x 105 were seeded into duplicate wells the day before the 
invasion experiment with OMZ175. There was no difference in the percentage of 
OMZ175 invading 0.5 x 105 and 1.0 x 105 BAEC (Figure 4.1). However, OMZ175 
invasion doubled when 2.0 x 105 BAEC were seeded into the wells; therefore, 
subsequent experiments were performed with 2.0 x 105 BAEC in each well of the 24-well 
plate to ensure adequate BAEC for experiments using strains with low invasion rates. 
The results of BAEC invasion assays are shown in Figure 4.2 and Table 4.2. 
Planktonic cultures of serotype c and e strains demonstrated very low BAEC invasion 
(range 0.0001% - 0.0011% of the S. mutans inoculated). The invasion rate for OMZ175 
was 0.0506%. BAEC invasion by serotype k strains was highly variable and ranged 
between 0.0002% for strain 608-1-PBB-06-03 to 0.5911% for NN2323M-1. Overall, 
serotype had a significant effect on BAEC invasion (p<0.0001). Serotype k strains had 
significantly higher rates of invasion than serotypes c and e strains (Table 4.3). There 
was no difference in BAEC invasion between OMZ175 and the serotype k strains 
collectively (p=0.5563). 
Endothelial cell invasion by S. mutans has been attributed to the presence of 
CBP genes cbm or cnm. OMZ175 bears the cnm gene and is a prototype for studying S. 
mutans invasion into endothelial cells. As in prior studies, OMZ175 invaded BAEC. No 
invasion was seen among five serotypes c and e strains, four of which possess genes 
for CBP. Thirteen of 20 serotype k strains demonstrated BAEC invasion by at least 
0.01% of the bacterial cells in the inoculum. Serotype k strain TLJ106-1 displayed 
significant BAEC invasion although it lacks both CBP genes. Six of the nine serotype k 
strains with the cbm gene had measurable BAEC invasion as did three of four cnm 
positive strains. The presence of cbm had a significant positive effect on BAEC invasion 
by planktonic cultures of S. mutans (p=0.0030); however, the cnm gene did not 
(p=0.1014). Significantly increased BAEC invasion was observed for cbm+/cnm- strains 
compared to strains lacking the cbm gene (Table 4.3). Analysis of the combined effects 
of serotype and genotype found that the mean invasion rate for serotype k strains was 
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similar between cbm positive and cnm positive strains (0.1586% and 0.1636%, 
respectively; Table 4.4). 
PA I/II is a well characterized virulence factor of S. mutans. Previous studies 
reported increased adhesion and endothelial cell invasion in strains lacking PA I/II. 
Figure 4.3 shows the BAEC invasion abilities of the thirteen strains, including OMZ175, 
typed for expression of PA I/II. All eight of the PA I/II negative strains possess one of the 
CBP, and all strains demonstrated BAEC invasion. Five PA I/II positive strains, two 
without CPB and three with cbm-/cnm+ were tested. In this group, low level BAEC 
invasion was observed for two of the cbm-/cnm+ strains. Interestingly, TLJ106-1, a PA 
I/II positive strain with no CBP gene had the second highest rate of BAEC invasion 
among all strains tested for BAEC invasion by planktonic cells of S. mutans. 
Excluding UA159 and OMZ175, eleven of the strains were clinical isolates from 
children living in the state of Alabama in the United States, and twelve were clinical 
isolates from Japan. The strains from Japan demonstrated significantly increased BAEC 
invasion compared to the strains from Alabama (p<0.0000). Four of the strains from 
Alabama were serotype c or e and possessed CBP genes; BAEC invasion was 
predicted due to the presence of the CBP genes but was not observed for these strains.   
 
DISCUSSION 
Oral streptococci, including S. mutans, have been identified in lesions of IE and 
atherosclerotic plaques (Kozarov, Sweier et al. 2006, Nakano, Inaba et al. 2006, 
Nakano, Nemoto et al. 2007, Abranches, Miller et al. 2011, Lapirattanakul, Nomura et al. 
2013, Fernandes, Oliveira et al. 2014). Additional evidence suggests a role for S. 
mutans in hemorrhagic stroke, ulcerative colitis and inflammatory bowel disease 
(Nakano, Hokamura et al. 2011, Kojima, Nakano et al. 2012, Kojima, Nomura et al. 
2014). At the nexus of these diseases, bacterial invasion of vascular endothelial cells is 
believed to occur at a site of endothelial cell injury triggering initiation of a local 
inflammatory response by the host (Nagata, de Toledo et al. 2011, Kozarov 2012). 
Certain strains of S. mutans have been shown to invade endothelial cells, whereas other 
strains do not (Abranches, Zeng et al. 2009, Lapirattanakul, Nomura et al. 2013). 
Characteristics of endothelial cell invasive S. mutans strains include both the serotype 
and the presence of certain bacterial cell surface proteins. Serotypes f and k were more 
frequently found in CVD lesions than the most common serotype, c (Nakano, Nemoto et 
al. 2007, Nakano, Nemoto et al. 2009). Furthermore, the presence of the CBP, Cbm and 
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Cnm, on the bacterial cell surface are key elements for endothelial cell invasion 
(Abranches, Miller et al. 2011, Nomura, Nakano et al. 2012, Otsugu, Nomura et al. 
2017). Surveys of large numbers of clinical S. mutans isolates have revealed that cnm is 
frequently observed in serotype f isolates and that cbm is most prevalent in serotype k 
strains (Nomura, Nakano et al. 2012).  
Our study focused on BAEC invasion of 20 serotype k strains with and without 
genes for CBP. Serotype c, e and f strains with CBP and well characterized strains 
UA159 and OMZ175 were investigated for comparisons. The highest rate of S. mutans 
invasion was observed with the serotype k strains compared to seven strains of 
serotypes c, e, and f. There were only two serotype f strains included in this study; 
however, the invasion by these strains was not statistically different from the serotype k 
strains. In addition to serotype, cell surface CBPs are key factors in endothelial cell 
invasion. Without regard for serotype, the cbm+/cnm- strains demonstrated significantly 
higher rates of BAEC invasion than strains lacking the cbm gene. Increased endothelial 
cell invasion by cbm positive compared to cnm positive strains of S. mutans is consistent 
with previous reports (Lapirattanakul, Nakano et al. 2011, Nomura, Nakano et al. 2012). 
Interestingly, as has been reported by others I found no invasion with two non-serotype k 
cbm+/cnm- strains (Lapirattanakul, Nomura et al. 2013). This suggests that perhaps 
serotype k in combination with a gene for CBP is necessary for S. mutans invasion of 
endothelial cells.  
The presence of a gene for CBP was not enough to confer endothelial cell 
invasion upon S. mutans as evidenced by eight strains with CBP genes that did not 
invade BAEC. Three of the non-invasive CBP positive strains were serotype k. 
Lapirattanakul, et al. reported that non-invasive S. mutans strains with CBP also 
displayed decreased binding to collagen in addition to lower rates of endothelial cell 
invasion compared to invasive strains (Lapirattanakul, Nakano et al. 2011). The CBP 
genes in the strains used in the present study were defined by DNA sequencing; thus, a 
possible explanation for lack of BAEC invasion by certain CBP gene positive strains is 
decreased CBP gene expression in these strains compared to the invasive strains. 
Additional testing by RT-PCR or Western-blot with cbm and cnm specific antibodies may 
be helpful to unravel this conundrum. 
Another S. mutans surface protein, PA I/II, has been proposed to play a role in 
endothelial cell invasion. Otsugu et. al. recently reported that CBP positive S. mutans 
strains lacking PA I/II aggregated, adhered to bovine heart valves, and in a rat model of 
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IE, generated bacterial masses on cardiac valves whereas strains positive for both CBP 
and PA I/II, or CBP negative, PA I/II positive strains did not display these traits (Otsugu, 
Nomura et al. 2017). PA I/II expression defects resulting from mutations in the gene and 
transcriptional processing, defects in the S. mutans sortase gene or low mRNA 
expression are more prevalent in serotypes f and k than in the most common serotype, c 
(Nakano, Nomura et al. 2008, Lapirattanakul, Nomura et al. 2015). S. mutans with PA I/II 
defects are less susceptible to phagocytosis, and as observed in an animal model, the 
duration of bacteremia as well as the severity of systemic inflammation was increased 
for PA I/II defective strains compared to PA I/II expressing isolates (Nakano, Nomura et 
al. 2004, Nakano, Inaba et al. 2006, Nomura, Hamada et al. 2007, Lapirattanakul, 
Nomura et al. 2015). Thirteen of the strains used in this study have been typed for PA I/II 
expression (five were PA I/II positive and eight were PA I/II negative). Each of the eight 
PA I/II negative strains also had a CBP gene, and all demonstrated BAEC invasion of at 
least 0.05%. In contrast, two of three cbm-/cnm+ strains expressing PA I/II demonstrated 
low levels of BAEC invasion; no invasion was observed with the third strain. One of 
these cbm-/cnm+ strains, OMZ175, expresses low levels of PA I/II, which may explain 
BAEC invasion at a similar rate to the least invasive PA I/II negative strain (Palmer, 
Miller et al. 2013). 
TLJ106-1, a serotype k strain which lacks both cbm and cnm but expresses PA 
I/II, demonstrated the second highest rate of S. mutans invasion in my study. Only one 
of six other cbm-/cnm- strains demonstrated modest (0.0121%) BAEC invasion; the PA 
I/II phenotype of this strain is unknown. Fifteen CBP-/PA I/II+ clinical strains in an ex vivo 
adherence model failed to adhere to bovine heart valve specimens demonstrating that 
PA I/II without CBP is insufficient for adherence, and likely invasion as well (Otsugu, 
Nomura et al. 2017). Strain TLJ106-1 raises the possibility of an additional unidentified 
endothelial cell binding protein(s) in this and perhaps in other strains.  
In conclusion, significant factors for endothelial cell invasion by planktonic S. 
mutans are the presence of cbm, serotypes k or f, and lack of PA I/II expression. 
Inasmuch as this was a study of serotype k strains, it is not unexpected that cbm was 
identified as a significant factor compared to cnm given that the cbm gene is 
predominantly found in serotype k strains (Nomura, Nakano et al. 2012). The cnm gene 
is predominant in serotype f strains (Nomura, Naka et al. 2013). Complete genetic 
analysis of strain TLJ106-1 and other CBP negative serotype k and f invasive strains of 
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S. mutans would help define other factors promoting endothelial cell invasion by the S. 







Table 4.1  S. mutans strains used in this Chapter. 
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Table 4.2  Planktonic S. mutans invasion of bovine aortic endothelial cells (BAEC).  
  
% S. mutans         
invading BAEC  
Strain  mean  SD  
107-1-PP3-07-02  0.0004%  0.0000  
196-1-PP3-07-04  0.0001%  0.0000  
219-1-PP30-07-07  0.0005%  0.0000  
UA159  0.0009%  0.0000  
241-1-PP3-07-09  0.0011%  0.0000  
119-1-PBP-01-01  0.0013%  0.0000  
OMZ175  0.0506%  0.0006  
106-1-PP3-06-01  0.0005%  0.0000  
151-1-PP19-07-05  0.0008%  0.0000  
505-1-PBB-05-06  0.0012%  0.0000  
548-1-PBT-05-04  0.0005%  0.0000  
573-1-PBS-05-03  0.0121%  0.0001  
578-1-PBB-06-01  0.0103%  0.0000  
608-1-PBB-06-03  0.0002%  0.0000  
AT1 0.1505%  0.0011  
FT1  0.0005%  0.0000  
LJ23  0.0006%  0.0000  
NN2193-1  0.3449%  0.0010  
NN2323M-1  0.5911%  0.0047  
OR22P1  0.0151%  0.0001  
SA31  0.0538%  0.0003  
SA53  0.2143%  0.0014  
TLJ106-1  0.4402%  0.0025  
TLJ11b  0.1550%  0.0007  
TLJ60a  0.4244%  0.0023  
TLJ85d  0.0778%  0.0010  









Table 4.3  Effects of serotype and genotype on invasion of bovine aortic endothelial cells (BAEC) by planktonic cultures of S. mutans. 
 
    S. mutans invasion  
vs. serotype 
e  vs. serotype f  vs. serotype k 
Serotype  n  mean  SD  p  p  p 
             
c  4  0.0005%  0.0000  0.7947  <0.0001  <0.0001 
e  1  0.0011%  0.0000    <0.0001  <0.0001 
f  2  0.0351%  0.0005      0.5563 
k  20  0.1547%  0.0026       
                          
             




/cnm+   
Genotype  n  mean  SD  p  p   
             
cbm-/cnm-  7  0.0920%  0.0024  0.0125  0.6897   
cbm+/cnm-  12  0.1330%  0.0024    0.0125   
cbm-/cnm+  8  0.0795%  0.0016       
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Table 4.4  Combined effects of genotype and serotype on BAEC invasion by planktonic 
S. mutans. 
    Strains  S. mutans invasion 
Genotype  Serotype  n  mean  SD 
         
cbm-/cnm-  c  1  0.0009%  0.0000 
  k  6  0.1112%  0.0011 
         
cbm+/cnm-  c  1  0.0004%  0.0000 
  f  1  0.0013%  0.0000 
  k  10  0.1586%  0.0026 
         
cbm-/cnm+  c  2  0.0003%  0.0000 
  e  1  0.0011%  0.0000 
  f  1  0.0464%  0.0005 






Figure 4.1   Titration of bovine aortic endothelial cells (BAEC) in 24-well plates used for 
BAEC invasion experiments. BAEC were counted, seeded into 24-well plates and 
incubated at 37oC, 5% CO2 for 22 hours. S. mutans strain OMZ175 was added to each 
well of BAEC for two hours prior to addition of fresh BAEC culture media containing 
penicillin and streptomycin. After a two-hour incubation, the BAEC were washed to 
remove the antibiotics followed by cold sterile dH2O added to each well to lyse the 
BAEC. The inoculum and each lysate were plated on blood agar plates and incubated 
for 2 days before counting cfu to determine the percentage of the OMZ175 inoculum that 































Figure 4.2  Bovine aortic endothelial cell (BAEC) invasion by planktonic cells of S. 
mutans. Overnight planktonic cultures of S. mutans grown in TSB were incubated with 
BAEC in the absence of antibiotics for 2 hours followed by a 2-hour incubation with 
penicillin and streptomycin to kill S. mutans on the exterior of the BAEC. After washing to 
remove the antibiotics, the BAEC were lysed with sterile ice-cold dH2O. The lysate was 
diluted and plated on blood agar plates to determine the cfu of invasion for each strain. 
The invasion assays were performed in duplicate, and each assay was repeated three 
times. The serotype of each strain is indicated above the graph, and the CBP genotype 
of each strain is shown at the bottom of the graph. The error bars represent standard 

































































































































































































c                        e            f                                                                k 
Genotype
cbm-/cnm- +  - - - - - - +  +  +  +  + +  - - - - - - - - - - - - - -
cbm+/cnm- - +  - - - +  - - - - - - - + +  +  + +  + +  +  + +  - - - -




Figure 4.3  Bovine aortic endothelial cell (BAEC) invasion by planktonic S. mutans 
serotype k strains typed for surface expression of PA I/II and collagen binding protein 
genes (cbm and cnm). OMZ175, a serotype f strain is included for comparison. 
Overnight cultures of planktonic S. mutans grown in TSB were incubated with BAEC in 
the absence of antibiotics for 2 hours followed by a 2-hour incubation with penicillin and 
streptomycin to kill S. mutans on the exterior of the BAEC. After washing the BAEC to 
remove antibiotics, the BAEC were lysed with ice cold water, and the lysates were 
diluted and plated on blood agar plates to determine the cfu invading BAEC. The 
invasion assays were performed in duplicate, and testing for each strain was repeated 
three times. The black bars represent cbm+/cnm- strains, hashed bars represent cbm-
/cnm+ strains and the stippled bars represent cbm-/cnm- strains. PA I/II surface 































































ENDOTHELIAL CELL INVASION BY S. MUTANS GROWING IN A BIOFILM 
LIFESTYLE   
INTRODUCTION 
S. mutans, a common inhabitant of the human oral microbiota, is considered a 
major pathogen in the destruction of mineralized tooth tissue known as dental caries 
(Hamada and Slade 1980, Hajishengallis, Parsaei et al. 2017). In addition, S. mutans  is 
detected in extra-oral pathologies such as IE and AT (Nakano, Inaba et al. 2006, 
Nakano, Nemoto et al. 2007, Nakano, Nemoto et al. 2009). The specific composition of 
cell-surface polysaccharides, rhamnose backbone with glucose side-chains, define S. 
mutans  into serotypes c, e ,f and k (Nakano and Ooshima 2009). Notably, serotype k 
has a deficit of glucose side-chains on the rhamnose backbone which may contribute to 
lower cariogenicity and increased blood virulence of these strains (Nakano, Nomura et 
al. 2004, Nakano, Nomura et al. 2010).  
Surface proteins of S. mutans  have also been associated with virulence. 
Expression of CBPs such as PA I/II (also named SpaP, AgB, P1 and PAc), WpaS, Cbm 
and Cnm on the surface of S. mutans impart this bacterium with the ability to interact 
with the extracellular matrix of tissues and organs (Brady, Maddocks et al. 2010, Aviles-
Reyes, Miller et al. 2017). PA I/II is also correlated with sucrose-independent attachment 
to salivary components on tooth surfaces (Koga, Okahashi et al. 1990). Strains with PA 
I/II expression defects are frequently serotype k, resistant to phagocytosis by 
polymorphonuclear leukocytes, and more likely to invade endothelial cells in the 
presence of other CBP (Nakano, Nomura et al. 2010, Lapirattanakul, Nomura et al. 
2015, Otsugu, Nomura et al. 2017). The CBP Cbm and Cnm are instrumental in S. 
mutans  virulence by enabling attachment to collagen at the site of dental caries as well 
as collagen in the extracellular matrix of endothelial cells, which facilitates S. mutans  
invasion into the endothelial cells (Abranches, Zeng et al. 2009, Nomura, Nakano et al. 
2012, Aviles-Reyes, Miller et al. 2017, Otsugu, Nomura et al. 2017). The genes for these 
CBP, cbm and cbm, are predominant in serotypes f and k strains of S. mutans 
(Abranches, Miller et al. 2011, Aviles-Reyes, Miller et al. 2017).  
The native habitat of S. mutans is within oral biofilm known as dental plaque. In 
addition to bacteria, the biofilm consists of a matrix composed of EPS mostly produced 
by the resident bacteria. Accounting for over 90% of the dry mass of the biofilm, the EPS 
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consists of exopolysaccharides, proteins, extracellular DNA (eDNA) and other polymeric 
substances, which collectively form the matrix within which the bacteria grow (Flemming 
and Wingender 2010). S. mutans  produces biofilm in the presence of sucrose and other 
dietary sugars. In transitioning from planktonic growth into a biofilm community, bacteria 
undergo major transcriptional and proteomic changes, which differentiate the bacteria 
within the biofilm from its planktonic form (Klein, DeBaz et al. 2010, Wright, Burns et al. 
2013). By using in vitro comparative transcriptome analyses of biofilm and free-living S. 
mutans cells, Shemesh et. al. reported significant differential expression in 
approximately 12% of S. mutans genes (Shemesh, Tam et al. 2007). Consequently, 
bacteria within a biofilm behave differently from their planktonic counterparts and 
properties observed in biofilm are often not predictable by study of the same bacteria in 
planktonic culture (Bowen and Koo 2011, Flemming, Wingender et al. 2016). One 
example is the loss of phenotypic antibiotic tolerance when bacteria disperse from 
biofilm to a planktonic state (Flemming, Wingender et al. 2016).  
Tobacco use is associated with increased risk for CVD and oral diseases, 
including caries (Wagenknecht, Balhaddad et al. 2018). Nicotine, a bioactive agent in 
tobacco, increases the in vitro growth and metabolism of S. mutans  strains grown in 
biofilm and planktonic cultures (Huang, Li et al. 2012). The basic amino acid, arginine, is 
present in saliva where the concentration of arginine is higher in caries-free compared to 
caries-susceptible subjects (Van Wuyckhuyse, Perinpanayagam et al. 1995, Sharma, 
Lavender et al. 2014). Free arginine is also found in the glycocalyx of endothelium, 
which is the point of S. mutans invasion into cardiovascular tissues (Tarbell and Pahakis 
2006, Flam, Eichler et al. 2007). In vitro studies demonstrate that the adhesive and 
structural properties of S. mutans biofilm are altered, biomass is increased and EPS is 
decreased in the presence of arginine (Sharma, Lavender et al. 2014, Zheng, Cheng et 
al. 2015). Arginine also causes downregulation of genes encoding virulence factors 
responsible for attachment, competence development and bacteriocin production 
(Chakraborty and Burne 2017). The effects of nicotine and arginine on S. mutans  biofilm 
were discussed in Chapter 3 of this dissertation.  
Certain S. mutans serotype k strains and strains bearing cbm and cbm genes 
have been shown to bind and invade endothelial cells in vitro and in vivo in tissue and 
whole animal models. All previous studies of endothelial cell invasion were performed 
with planktonic cultures of S. mutans. Considering the biological differences between 
bacteria in planktonic and biofilm phases, I investigated endothelial cell invasion by S. 
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mutans in single-species sucrose-induced biofilm. The effects of CBP, PA I/II and 
serotype k were examined and compared to endothelial cell invasion by the same S. 
mutans strains grown in planktonic conditions and was presented in Chapter 4 of this 
tome. In addition, the effects of nicotine and arginine on S. mutans biofilm invasion of 
endothelial cells were also surveyed.  
 
MATERIALS AND METHODS 
Bacterial Strains and Growth Conditions 
The strains of S. mutans used in this study are listed in Table 5.1. Frozen stock 
of each strain was inoculated into tryptic soy broth (TSB, Becton Dickinson and Co., 
Sparks, MD, USA) and incubated at 37oC in 5% CO2 overnight prior to inoculating into 
TSBS (Sigma-Aldrich, St. Louis, MO, USA) for biofilm formation in 6-well plates. In 
certain experiments, 10 mg/ml arginine (Sigma-Aldrich) or 4 mg/ml nicotine (Sigma-
Aldrich) was added to the TSBS. Biofilm formation occurred over 20 hours at 37oC, 5% 
CO2. Biofilm was washed three times with sterile 0.9% NaCl before scraping the biofilm 
from the plastic and transferring to a sterile microfuge tube. The harvested biofilm was 
centrifuged at 13,000 rpm for 5 minutes and washed once with sterile 0.9% NaCl before 
sonication at 30 amps for 10 seconds per cycle for up to four cycles. Subsequent to 
sonication, the S. mutans biofilm was diluted 1:100 in BAEC growth media without 
penicillin and streptomycin. The diluted S. mutans was held at 37OC while the BAEC 
were washed in preparation for addition of the inoculum.  
 
BAEC Culture 
BAEC growth media consisted of DMEM (Corning Life Sciences, New York, 
USA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Flowery Branch, 
GA), 2 mM L-glutamine (Corning Life Sciences), 100 IU penicillin (Corning Life 
Sciences) and 100 ug/ml streptomycin (Corning Life Sciences) at 37oC with 5% C02. 
Cultured BAEC were removed from the surface of the flask by a five-minute incubation 
with 0.25% trypsin protease (Hyclone, GE Healthcare Life Sciences, Pittsburgh, PA, 
USA). After washing the detached cells with BAEC growth media, the BAEC were 
seeded into 24-well plates or into T-75 flasks for further culture. The BAEC used for 





BAEC Invasion Assay 
The BAEC invasion assay was modified from that developed by Abranches et. al. 
(Abranches, Miller et al. 2011). Briefly, each well of a 24-well plate was seeded with 2.0 
x 105 BAEC in 1.0 ml of BAEC growth media with antibiotics, and the plate was 
incubated for 20 hours at 37OC, 5% CO2. After incubation, the BAEC were washed 3 
times with 37OC DPBS (GE Healthcare, Life Sciences). After discarding the final wash, 
1.0 ml of diluted S. mutans in BAEC growth media without antibiotics was added to 
duplicate wells of BAEC, and the plate was incubated for 2 hours at 37OC, 5% CO2. 
During the incubation, the residual S. mutans inoculum was diluted and plated onto 
blood agar plates to determine the number of colony forming units (cfu)/ml in the 
inoculum. After the incubation, the BAEC were washed three times with warm DPBS 
followed by addition of 1.0 ml of BAEC growth media with antibiotics, then incubation at 
37OC, 5% CO2 for 2 hours. The BAEC were again washed three times with warm DPBS 
to remove the antibiotics before adding 1.0 ml of ice-cold sterile H2O to each well of 
BAEC and incubating at room temperature for 20 minutes to lyse the BAEC. After BAEC 
lysis, each well was scraped to remove BAEC from the plastic surface, and the lysate 
from each well was plated onto blood agar plates to determine the cfu of invading S. 
mutans. For strains with high invasion rates, 1:10 and 1:100 dilutions of the lysate were 
required to obtain accurate quantitation.  
The blood agar plates were incubated at 37OC, 5% CO2 for two days before 
colony counting by using the ProtoCOL automatic colony counting instrument and 
software (Symbiosis, Fredrick, MD, USA). The percent of S. mutans invading BAEC for 
each well was calculated as: cfu/ml invading BAEC divided by cfu/ml in the inoculum 
times 100. Each strain of S. mutans was tested in duplicate in three separate 




Basic statistics (mean, standard deviation) were computed before statistical 
evaluation by using analyses of ranks and analysis of variance (ANOVA). When non-







Previously published endothelial cell invasion assays have been performed with 
planktonic cultures of S. mutans. In order to adapt biofilm cultures to the BAEC invasion 
assay, I washed and then scraped 24-hour S. mutans biofilm from the wells of a 6-well 
plate before sonicating the biofilm to disrupt it further. Figure 5.1 shows BAEC invasion 
by OMZ175 biofilm after two, three and four 10-second cycles of sonication at 30 amps. 
BAEC invasion after 2 cycles of sonication was not different from biofilm without 
sonication. Increasing BAEC invasion was observed with subsequent sonication cycles. 
All subsequent BAEC invasion experiments were performed with biofilm after four cycles 
of sonication. 
BAEC invasion was calculated as the percentage of the inoculum from each 
strain that invaded BAEC. As shown in Table 5.2, BAEC invasion by biofilm ranged from 
0.0001% to 0.8718% with 10 strains demonstrating invasion rates greater than 0.01%. 
Figure 5.2 displays the BAEC invasion data with the strains grouped by serotype and 
CBP genotype. Compared to the strains obtained from Osaka University Graduate 
School of Dentistry, the strains isolated from subjects at the University of Alabama 
School of Dentistry did not invade BAEC (p<0.0001). 
Nine of the 20 serotype k strains had invasion rates of greater than 0.01%. There 
was no difference in invasion between the serotype k strains and the serotype f strain, 
OMZ175 (Table 5.3). Similarly, the serotype c and e strains were not statistically 
different. The serotype k strains and OMZ175 demonstrated statistically greater 
endothelial cell invasion than UA159 and 241-1-PP3-07-09.  
When analyzed by CBP genotype (Table 5.3), cbm+ and cnm+ were significant 
predictors of BAEC invasion compared to cbm- strains (p<0.0001 and 0.0220, 
respectively). Invasion by cbm+/cbm- strains was not significantly different from cbm-
/cnm+ strains. Strains without CPB demonstrated significantly less BAEC invasion than 
strains with either cbm or cbm (p<0.0001). BAEC invasion by TLJ60a biofilm of 0.87% 
was the highest of all strains tested and may skew the statistical analysis of the cbm-
/cbm+ group of strains, wherein BAEC invasion of the remaining strains averaged 
0.0380%.  
The PA I/II phenotype was known for a subset of 15 strains. Figure 5.3 displays 
the BAEC invasion data grouped by PA I/II phenotype and CBP genotype. Strains 
expressing PA I/II were less invasive than strains that did not express PA I/II 
(p=<0.0001). PA I/II-, cbm-, cbm+ strains averaged 0.407% BAEC invasion and PA I/II-, 
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cbm+, cbm- strains averaged 0.109% invasion (Table 5.4). Invasion by the PA I/II+ strains 
was not different between cbm-/cnm- and cbm-/cbm+ strains. 
We next compared BAEC invasion by biofilm to the invasion of planktonic 
cultures presented in the previous chapter. Planktonic cultures of 14 strains and biofilm 
from 10 strains demonstrated invasion of BAEC by at least 0.01% of the S. mutans  
inoculum (Figure 5.4, Table 5.2). Overall, there was no difference in BAEC invasion 
between planktonic cultures and biofilm (p=0.7635). There were 10 strains in which both 
biofilm and planktonic cultures invaded EC. Biofilm from 4 of the strains invaded better 
than planktonic cultures from the same strain, but the difference was significant for only 
TLJ60a (p=0.0484). Although invasion by FT1 biofilm was lower than the 0.01% 
threshold, invasion by planktonic cultures of FT1 was significantly lower than the biofilm 
invasion (p<0.0001). For six strains, planktonic cultures demonstrated better BAEC 
invasion than biofilm with significantly increased invasion with planktonic cultures of AT1, 
NN2193-1, SA31 and 578-1-PBB-06-01 compared to the respective biofilm. For biofilm, 
the presence of CBP was associated with increased BAEC invasion, and there was no 
difference between cbm+ vs cmn+ strains (Table 5.3). In contrast for planktonic cultures, 
cbm+ increased BAEC invasion (p=0.01) compared to cmn+ and CBP- strains (Table 
4.3). Greater BAEC invasion occurred for PA I/II- strains than for PA I/II+ strains for both 
biofilm and planktonic cultures (p<0.0001, Figure 5.5, Table 5.4). In comparisons 
between biofilm and planktonic culture, only PA I/II-,cbm+, cbm- strains exhibited 
significantly different invasion rates between cells in biofilm and planktonic culture 
(p=0.0182). 
In order to determine whether the EPS in biofilm affected BAEC invasion by S. 
mutans, the biofilm was washed three times with sterile saline after sonication. Eight 
strains were selected for comparison (Figure 5.6). Post-sonication, the biofilm from each 
strain was divided into two microfuge tubes, and one of the tubes received three sterile 
saline washes. The washed and not washed biofilm were separately diluted into BAEC 
growth media and tested in parallel BAEC invasion assays. Additional washing of the 
biofilm post-sonication resulted in increased BAEC invasion for all strains. Increases in 
BAEC invasion varied among the strains and ranged from two-fold OMZ175 to 147-fold 
for biofilm.  
We previously demonstrated that 4 mg/ml nicotine significantly increased biofilm 
biomass and metabolic activity, whereas 10 mg/ml arginine had no significant effect 
compared to biofilm grown in TSBS alone. When nicotine and arginine were combined, 
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the biomass and metabolic activity significantly increased albeit to a lesser extent than 
for nicotine alone. Nine strains were selected to measure the effects of nicotine and 
arginine treatment of S. mutans  biofilm on endothelial cell invasion (Figure 5.7). Nicotine 
and arginine were added during S. mutans biofilm formation, and since the biofilm was 
washed prior to S. mutans inoculation, the cultured BAEC were not exposed to these 
supplements. Across the nine strains, adding nicotine and arginine to the TSBS growth 
media had no significant effect on BAEC invasion by S. mutans  biofilm. While S. mutans  
biofilm biomass and metabolic activity increased with addition of nicotine or arginine plus 
nicotine to TSBS (Chapter 3), BAEC invasion by YT1 and TLJ60a decreased when the 
biofilm was grown in the presence of nicotine. In contrast, invasion by OMZ175 biofilm 
grown in arginine plus nicotine was more than three-fold greater than biofilm grown in 
any of the other growth media. 
 
DISCUSSION 
S. mutans is an obligate human pathogen naturally habituating the dental plaque, 
a multispecies biofilm formed on tooth hard surfaces (Lemos, Palmer et al. 2019). The 
cariogenic potential of S. mutans is attributed to three core traits: (1) the ability to 
synthesize large quantities of EPS from sucrose, (2) ability to metabolize carbohydrates 
into organic acids which reduce the local pH in the biofilm (acidogenicity) and (3) the 
ability to thrive in conditions of environmental stress, especially low pH (aciduricity) 
(Lemos, Palmer et al. 2019). S. mutans adherence to the tooth surface and initiation of 
biofilm formation is dependent upon surface proteins of S. mutans, including 
glucosyltransferases, glucan-binding proteins, PA I/II and CBP (Palmer, Miller et al. 
2013). In addition to the role in adherence to tooth surfaces, S. mutans strains with CBP 
and defects in PA I/II expression have been implicated in a variety of extra-oral systemic 
diseases such as IE, AT, IgA nephropathy, and in the brain, hemorrhagic stroke, 
cerebral microbleeds and cogitative impairment  (Nakano, Nomura et al. 2008, Nakano, 
Nemoto et al. 2009, Nomura, Naka et al. 2013, Misaki, Naka et al. 2016, Watanabe, 
Kuriyama et al. 2016, Otsugu, Nomura et al. 2017, Inenaga, Hokamura et al. 2018). The 
proposed mechanism of infection after S. mutans  enters the bloodstream is that in the 
absence of  PA I/II expression, CBP facilitate S. mutans  invasion of endothelial cells 
lining the blood vessel walls. Previous studies of S. mutans invasion of endothelial cells 
have been performed with planktonic cultures (Stinson, Alder et al. 2003, Abranches, 
Zeng et al. 2009, Abranches, Miller et al. 2011, Nagata, de Toledo et al. 2011, 
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Lapirattanakul, Nomura et al. 2013, Nomura, Naka et al. 2013). To my knowledge, there 
have been no endothelial cell invasion studies performed with S. mutans biofilm.  
I assessed biofilm from 21 clinical isolates and two type strains of S. mutans for 
capacity to invade endothelial cells. Because early studies of extra-oral infections 
reported increased prevalence of serotype k strains in IE and AT tissues, I focused my 
study on serotype k strains with known CBP genotype. Endothelial cell invasion by S. 
mutans biofilm was diverse across the strains and ranged from essentially non-invasive 
to invasion by almost 0.9% of the S. mutans  inoculum. The presence of CBP genes was 
significant for endothelial cell invasion, but whether the strain carried the cbm or the cbm 
gene was not significant. Interestingly, the presence of cbm or cnm was not sufficient to 
confer the ability to invade as a number of cbm+ and cnm+ strains demonstrated 
minimal or no endothelial cell invasion. In a study of planktonic S. mutans, Lapirattanakul 
et. al. reported low levels of collagen binding, extremely low levels of endothelial cell 
adhesion and lack of invasion for certain strains bearing cbm and cnm genes 
(Lapirattanakul, Nomura et al. 2013). The variations in collagen binding and interactions 
with endothelial cells among strains with CBP genes may result from differences in 
levels of cbm and cnm protein expression. Currently, expression levels of these CBP is 
unknown, but this knowledge would be beneficial for understanding of the mechanisms 
involved in the strain-to-strain variability and is worthy of additional investigation. 
PA I/II expression defects are the result of point and frameshift mutations in the 
spaP gene encoding PA I/II as well as a frameshift mutation in the sortase gene which is 
responsible for anchoring the PA I/II protein to the cell surface (Lapirattanakul, Nomura 
et al. 2015). PA I/II expression defects were reported in approximately 7% of clinical 
isolates with expression defects found in 39% of serotype f strains and in 100% of 
serotype k strains isolated from subjects in Thailand  (Nakano, Tsuji et al. 2006, 
Lapirattanakul, Nomura et al. 2015). Nomura and colleagues reported that S. mutans  
strains lacking PA I/II (CBP+/PA I/II-) expression demonstrated increased endothelial cell 
adhesion and invasion rates compared to CBP+/PA I/II+ strains, while CBP-/PA I/II+ 
strains demonstrated negligible adhesion and invasion (Nomura, Naka et al. 2013). In 
my study, S. mutans  strains lacking PA I/II expression demonstrated significantly higher 
endothelial cell invasion than strains expressing PA I/II for both biofilm and planktonic 
cultures. This observation was striking when comparing cnm+ strains with and without 
PA I/II expression. Because the strains with PA I/II expression did not include cbm+ 
strains, one can only hypothesize a similar comparison for PA I/II+/cbm+ strains. The 
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crystal structure of S. mutans PA I/II reveals unique elongated fibrillar architecture 
forming an extended stalk on the bacterial cell surface (Brady, Maddocks et al. 2010). 
Stearic hindrance by PA I/II may block CBP access to the endothelial cell surface and 
this may explain the enhanced invasion by CBP+/PA I/II- strains. At this time the 
crystalline structures of Cbm and Cnm have not been determined; thus, speculation of 
stearic hinderance of CBP is merely a theoretical explanation of the observations. 
In the present study, PA I/II expressing strains from planktonic cultures had a 
non-significant increase in invasion compared to biofilm S. mutans. Shemesh et. al. 
reported a 56-fold increase in PA I/II mRNA in the presence of 1% sucrose compared to 
planktonic culture. Thus increased PA I/II expression in biofilm compared to planktonic 
S. mutans cells might be predicted to diminish endothelial cell binding and invasion by 
biofilm (Shemesh, Tam et al. 2007). In addition, it raises into question the decrease in 
invasion by S. mutans biofilm observed in seven strains reported to lack PA I/II 
expression. Inasmuch as reported PA I/II expression defects were likely not due to 
deletion of the gene, one might speculate that in the biofilm phase, PA I/II expression 
was increased sufficiently to inhibit endothelial cell invasion by at least some of the 
seven PA I/II-, cbm+ strains. Indeed PA I/II expression by these strains was detected in 
cells grown without sucrose; thus, it is not known whether growth in sucrose would 
increase PA I/II expression to a detectable level in these strains (Nakano, Tsuji et al. 
2006, Lapirattanakul, Nomura et al. 2015, Otsugu, Nomura et al. 2017). 
The presence of nicotine during sucrose-induced biofilm production results in 
increases of both S. mutans biomass and EPS. Not surprisingly, nicotine significantly 
increases expression of the glucosyltransferase gene gtfC, which accounts for increased 
EPS production (Li, Huang et al. 2013). Nicotine upregulates certain virulence 
associated genes (ldh and nlmC) as well as genes associated with the 
phosphotransferase system of S. mutans  (Li, Huang et al. 2016). In contrast, nicotine 
had no effect on expression of PA I/II or sortase A, which controls PA I/II expression 
through a LPXTGX motif (Li, Huang et al. 2013). The invasion of BAEC by S. mutans  
biofilm was not increased when the biofilm was grown in the presence of nicotine, and 
invasion was significantly suppressed for two strains that demonstrated high invasion by 
biofilm grown in TSBS alone. The suppression was observed for both cbm+ (YT1) and 
cbm+ (TLJ60a) strains. These data suggest that nicotine may downregulate expression 
of the CBP thereby decreasing the ability of the bacteria to invade endothelial cells. 
Additional experiments investigating CBP expression in the presence of sucrose and 
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nicotine such as using qRT-PCR or western blot analyses to quantitate CBP expression 
may help explain this observation. 
Diverse genotypic and phenotypic heterogeneity is observed between strains of 
S. mutans, and not all strains are equally virulent (Palmer, Miller et al. 2013, Song, 
Wang et al. 2013, Lemos, Palmer et al. 2019). This study of 23 clinical and type strains 
found, great heterogeneity in endothelial cell invasion across all strains and among 
strains bearing the same CBP genotype and PA I/II phenotype. Strains capable of 
endothelial cell invasion had varied invasion rates between planktonic and biofilm cells. 
For some strains, increased endothelial cell invasion was observed for planktonic cells 
(p=0.0000), whereas for other strains markedly better invasion was observed for biofilm 
cells (p=0.0480). Based on PA I/II expression, cbm-/cbm- genotype and extremely low 
collagen binding reported for TLJ106-1, this strain was not predicted to invade 
endothelial cells; however, endothelial cell invasion was observed for planktonic and 
biofilm cells from this strain (Lapirattanakul, Nakano et al. 2011). These data suggest a 
yet to be unidentified virulence factor or mechanism is employed by strain TLJ106-1 for 
endothelial cell invasion. Screening of additional clinical strains from diverse 
geographical areas may reveal similar or additional virulence mechanisms for 
endothelial cell invasion. Indeed, I observed significant differences in endothelial cell 
invasion from clinical strains collected in rural Alabama, Japan and Thailand. 
The increased endothelial cell invasion observed after washing sonicated biofilm 
was an unanticipated observation, which suggests that elements of the biofilm matrix 
may negatively influence S. mutans invasion of the endothelial cell. Bacteria remained 
after washing as evidenced by the endothelial cell invasion, suggesting that extracellular 
components of the biofilm matrix were removed by the additional washing steps. The 
biofilm matrix, or EPS, is composed of a collection of polysaccharides, proteins, 
extracellular DNA (eDNA) and lipids produced by the bacteria within the biofilm 
(Flemming and Wingender 2010, Okshevsky and Meyer 2015). The eDNA is associated 
with bacterial membrane vesicles trapped within the biofilm (Jakubovics and Burgess 
2015). The effect of the EPS on endothelial cell invasion may be passive or active. 
Adsorption of the long loop structure of eDNA, which can extend up to 300 nm from the 
bacterial cell surface, may create steric hinderance, and membrane vesicles with surface 
CBP may block intact S. mutans from binding (Okshevsky and Meyer 2015). One 
example of active interference is changes in the hydrophobicity of the bacterial cell 
surface caused by eDNA (Okshevsky and Meyer 2015). Alternatively, the components of 
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the EPS in the inoculum may affect the endothelial cell directly making it less receptive 
to S. mutans invasion. Certainly, more investigation is needed to understand the 
influence of washing biofilm after sonication upon endothelial cell invasion by S. mutans. 
These data and investigations by others demonstrate that the presence of cbm or 
cbm concurrently with absence of PA I/II expression is not alone sufficient to predict 
endothelial cell invasion by S. mutans. Studies by Shemesh et al. indicate that bacteria 
in biofilms express different genes according to the substrate (polystyrene, 
hydroxyapetite, titanimu and composite) as part of the adjustment to the 
microenvironment (Shemesh, Tam et al. 2010). This leads to speculation that gene 
expression upon S. mutans  encounter with endothelial cells may be quite different from 
gene expression upon contact with the tooth, or in the case of the present study, 
polystyrene surface, leading to upregulation of genes for a different set of attachment 
and virulence factors. Studies comparing mRNA from S. mutans adhered to ploystyrene, 
tooth and cardiac valve surfaces would begin to address the effect of these different 
surfaces on S. mutans. Additional studies are necessary to further elucidate differences 
among diverse strains of S. mutans and to to define those capable of binding and 




Table 5.1 S. mutans strains used in this Chapter.   
          
Strain  serotype  cbm  cnm   Source 




k  -  - 
 
S. Momeni, N. Childers 
505-1-PBB-05-06 
 
k  -  - 
 
S. Momeni, N. Childers 
548-1-PBT-05-04  
 
k  +  - 
 
S. Momeni, N. Childers 
573-1-PBS-05-03 
 
k  -  - 
 
S. Momeni, N. Childers 
578-1-PBB-06-01 
 
k  +  - 
 
S. Momeni, N. Childers 
608-1-PBB-06-03 
 
k  +  - 
 
S. Momeni, N. Childers 
AT1  k  +  -  K. Nakano2 
FT1 
 

























































k  +  - 
 
K. Nakano 
UA159   c  -  -  ATCC 700610 
241-1-PP3-07-09  e  -  +  S. Momeni, N. Childers 
OMZ175  f  -  +  B. Guggenheim 
         
 
1University of Alabama School of Dentistry, Birmingham, AL, USA 





Table 5.2  Invasion of bovine aortic endothelial cells (BAEC) by S. mutans. 
  BAEC Invasion (% S. mutans)  Biofilm vs. 
Strain  Biofilm  Planktonic  Planktonic 
  mean  SD  mean   SD  p-value 
FT1  0.00%  0.00%  0.00%  0.00%  0.1534 
TLJ106-1  0.08%  0.09%  0.44%  0.25%  0.0018 
106-1-PP3-06-01  0.00%  0.00%  0.00%  0.00%  0.4960 
505-1-PBB-05-06  0.00%  0.00%  0.00%  0.00%  0.5989 
573-1-PBS-05-03  0.00%  0.00%  0.01%  0.01%  0.1581 
151-1-PP19-07-05  0.00%  0.00%  0.00%  0.00%  0.2799 
NN2193-1  0.08%  0.06%  0.34%  0.10%  0.0009 
NN2323M-1  0.03%  0.01%  0.59%  0.47%  0.0465 
SA31  0.01%  0.01%  0.05%  0.03%  0.0001 
TLJ11b  0.10%  0.05%  0.16%  0.07%  0.4608 
TLJ85d  0.03%  0.01%  0.08%  0.10%  0.5339 
548-1-PBT-05-04  0.00%  0.00%  0.00%  0.00%  0.0087 
578-1-PBB-06-01  0.00%  0.00%  0.01%  0.00%  0.1805 
608-1-PBB-06-03  0.00%  0.00%  0.00%  0.00%  0.5786 
YT1  0.53%  0.91%  0.06%  0.05%  0.5088 
LJ23  0.00%  0.00%  0.00%  0.00%  0.4306 
OR22P1  0.02%  0.02%  0.02%  0.01%  0.0196 
SA53  0.06%  0.06%  0.21%  0.14%  0.5776 
TLJ60a  0.87%  0.22%  0.42%  0.23%  0.5608 
OMZ175  0.12%  0.22%  0.05%  0.06%  0.2823 
AT1  0.00%  0.01%  0.15%  0.11%  0.0000 
UA159  0.00%  0.00%  0.00%  0.00%  0.1382 









Table 5.3 Effects of serotype and genotype on invasion of bovine aortic endothelial cells (BAEC) by S. mutans biofilm cells. 
  Strains  S. mutans invasion  vs. serotype e  vs. serotype f  vs. serotype k 
Serotype  (n)  mean  SD  p  p  p 
             
c  1  0.0013%  0.0000  0.2561  0.0614  0.0416 
e  1  0.0001%  0.0000    0.0015  0.0004 
f  1  0.1294%  0.0022      0.8282 
k  20  0.0881%  0.0028       
             
  Strains  S. mutans invasion  vs. cbm+/cnm-  vs. cbm-/cnm+   
Genotype  (n)  mean  SD  p  p   
             
cbm-/cnm-  7  0.0150%  0.0004  0.0009  0.0220   
cbm+/cnm-  10  0.0759%  0.0029    0.3709   








Table 5.4  Effects of PA I/II phenotype and CBP genotype on biofilm and planktonic S. mutans cell invasion of BAEC.  
    % S. mutans  
vs. PA I/II-, 
cbm+, cnm-  
vs. PA I/II+, 
cbm-, cnm-  




(n)  mean  SD  p-value   p-value   p-value  
Biofilm                         
PA I/II-, cbm-, cnm+  2  0.407%  0.442%  0.0516  0.0003  <0.0001 
PA I/II-, cbm+, cnm-   7  0.109%  0.356%    0.0109  0.0002 
PA I/II+, cbm-, cnm-  3  0.032%  0.063%      0.3642 
PA I/II+, cbm-, cnm+  3  0.074%  0.169%       
             
Planktonic                         
PA I/II-, cbm-, cnm+  2  0.319%  0.211%  0.9947  0.001  <0.0001 
PA I/II-, cbm+, cnm-   7  0.222%  0.283%    <0.0001  <0.0001 
PA I/II+, cbm-, cnm-  3  0.188%  0.328%      0.5475 





Figure 5.1  The effect of sonication on S. mutans OMZ175 biofilm invasion of bovine 
aortic endothelial cells (BAEC). Planktonic cultures of OMZ175 were inoculated into 
TSBS and seeded into 6-well plates. After a 20-hour incubation at 37o, 5% CO2, the 
biofilm was washed, harvested by scraping, and then divided into 4 microtubes. The 
disrupted biofilm was sonicated 0, 2, 3 or 4 times with 30 amps for 10 seconds per cycle 
and stored on ice for at least 1 minute before each subsequent cycle. The error bars 


































Figure 5.2  Bovine aortic endothelial cell (BAEC) invasion by S. mutans biofilm divided 
by serotype and CBP. Overnight biofilm cultures of S. mutans grown in TSBS were 
sonicated, then incubated with BAEC in the absence of antibiotics for 2 hours followed 
by a 2-hour incubation with penicillin and streptomycin to kill S. mutans cells that did not 
invade the BAEC. After washing the BAEC to remove antibiotic, the BAEC were lysed 
with ice cold water. The lysate was diluted and plated on blood agar plates to determine 
the number cfu of S. mutans that invaded BAEC. The invasion assays were performed in 
duplicate, and each assay was repeated three times. The serotype and genotype of the 


































































































































































































cbm-/cnm- +                                      +    +     +    +    +     +   
cbm+/cnm- +     +     +    + +    +     +    +    +    +
cbm-/cnm+ +     +                                                                                                                +    +   +    +
Serotype





Figure 5.3 Bovine aortic endothelial cell (BAEC) invasion by S. mutans biofilm divided by 
PA I/II expression and CBP. Overnight biofilm cultures of S. mutans grown in TSBS were 
sonicated,  then incubated with BAEC in the absence of antibiotics for 2 hours followed 
by a 2-hour incubation with penicillin and streptomycin to kill S. mutans cells that had not 
invaded the BAEC. After washing the BAEC to remove the antibiotics, the BAEC were 
lysed with ice cold water and then plated on blood agar plates to determine the number 
of colony forming units from each strain that invaded the BAEC. The invasion assays 
were performed in duplicate, and each assay was repeated three times. The phenotypes 
and genotypes of the strains are shown at the top of the graph. Black bars represent 
cbm+/cbm- strains, bars with black and white diagonal lines are cbm-/cbm+ strains and 





































































PA I/II negative                                                         PA I/II positive




Figure 5.4  Paired comparison of biofilm and planktonic cultures of S. mutans in ability to 
invade bovine aortic endothelial cells (BAEC). Planktonic cultures were grown in TSB 
overnight, and then washed 3 times with sterile 0.9% NaCl before addition to 24-well 
plates of BAEC without antibiotics. Biofilm was grown for 24-hours in TSBS followed by 
4 cycles of sonication before addition to BAEC cultures without antibiotics. The BAEC 
and S. mutans were incubated for 2 hours at 37oC, 5% CO2. After washing to remove 
unbound S. mutans, BAEC growth media with penicillin and streptomycin was added to 
the BAEC for two hours followed by washing to remove the antibiotics. Lastly, the BAEC 
were lysed with ice cold water, and the lysate was plated onto blood agar plates to 
determine the number of colony forming units of invading S. mutans. Planktonic S. 
mutans invasion is shown by the black bars, and the gray bars represent invasion by S. 
mutans grown in biofilm. The genotype ofeach strain is shown on the graph. Error bars 





























































































































































cbm-/cnm- +      +        +       +       +       +         
cbm+/cnm- +       +        +       +       +       +       +       +       +       +        










Figure 5.5  Comparison of S. mutans biofilm and planktonic cell invasion of bovine aortic 
endothelial cells (BAEC). The effects of PA I/II expression and the presence of the 
collagen binding protein genes cnm and cbm are shown in the bars. Error bars represent 
the standard deviation of all strains with the stated phenotypes and genotypes. Each 




























PA I/II-, cbm-, cnm+
PA I/II-, cbm+, cnm-
PA I/II+, cbm-, cnm-
PA I/II+, cbm-, cnm+





Figure 5.6 The effects of post-sonication washes on invasion of bovine aortic endothelial 
cells by S. mutans biofilm. S. mutans 24-hour biofilm grown in TSBS was sonicated for 
four cycles of 30 amps, 10 seconds. After sonication, the S. mutans was nor washed or  
washed 3 times with sterile 0.9% NaCl ,prior to BAEC invasion assays. The black bars 
represent S. mutans that was not washed post-sonication and gray bars represent 
biofilm washed 3 times after sonication. Strains TLJ106-1, TLJ60a and YT1 were tested 
in two separate experiments whereas all other strains were tested in one experiment. 































































Figure 5.7  The effects of arginine (10 mg/ml) and/or nicotine (4 mg/ml) treatment of S. 
mutans biofilm on the ability of S. mutans to invade bovine aortic endothelial cells 
(BAEC). Biofilm was grown for 24-hours in the presence of 10 mg/ml arginine (black and 
white diagonal), 4 mg/ml nicotine (gray), combined arginine and nicotine (black and gray 
diagonal) and TSBS alone (black). After washing to remove growth media, each biofilm 
underwent 4 cycles of sonication before a 2-hour incubation with BAEC in the absence 
of antibiotics. After washing to remove unbound S. mutans, BAEC growth media with 
penicillin and streptomycin were incubated with the BAEC for two hours followed again 
by washing. Lastly, the BAEC were lysed with ice cold water, and the lysate was plated 
onto blood agar plates to determine the number of cfu of invading S. mutans. The error 





















































































10 mg/ml arginine + 4 mg/ml nicotine
Serotype        c          f          k          k          k          k          k          k         k          k
cbm+/cnm- - - +         +          +          - - - - -
cbm-/cnm+ - +          - - - +          +         +         - -




SUMMARY, CONCLUSIONS AND FUTURE DIRECTIONS 
This dissertation is a study of endothelial cell invasion by S. mutans conceived 
based upon earlier investigations that reported evidence of S. mutans in atherosclerotic 
plaques and lesions of IE (Nakano, Inaba et al. 2006, Nomura, Nakano et al. 2006, 
Nakano, Nemoto et al. 2007, Nakano, Nemoto et al. 2009, Nakano and Ooshima 2009, 
Nakano, Nomura et al. 2010, Nomura, Naka et al. 2013, Otsugu, Nomura et al. 2017). 
Endothelial cell invasion by S. mutans is associated with the CBP Cbm and Cnm which 
are predominantly found in serotypes f and k strains of S. mutans. (Abranches, Miller et 
al. 2011, Lapirattanakul, Nakano et al. 2011, Nomura, Nakano et al. 2012, 
Lapirattanakul, Nomura et al. 2013). Previous studies demonstrating endothelial cell 
invasion by S. mutans were performed with planktonic cultures as opposed to the dental 
plaque habitat wherein S. mutans maintains a biofilm lifestyle. Separate studies of S. 
mutans serotypes c, e and f documented the effects of nicotine and arginine on biofilm 
formation, but no study addressed S. mutans serotype k strains (Huang, Li et al. 2012, 
Li, Huang et al. 2014, Huang, Li et al. 2015, Li, Huang et al. 2016, Huang, Zhang et al. 
2017). Inasmuch as nicotine, a component of tobacco, is associated with both 
compromised cardiovascular and oral health, I wondered whether nicotine treatment of 
S. mutans would influence its ability to invade endothelial cells. Prior studies 
demonstrated that S. mutans biofilm grown in the presence of arginine produced a more 
fragile EPS matrix compared to biofilm grown in the absence of arginine (Sharma, 
Lavender et al. 2014, Huang, Zhang et al. 2017). Given this prior knowledge, I 
investigated the effects of nicotine and arginine on biofilm formation by 33 serotyped and 
CBP genotyped strains of S. mutans with a focus on serotype k strains. In order to put 
my investigations into the context of the previous investigations, comparisons of 
endothelial cell invasion by free-living (planktonic) and biofilm S. mutans were 
undertaken. The following are my conclusions from these studies.  
 
A ROLE FOR BACTERIA IN THE EVOLUTION OF ATHEROSCLEROSIS  
AT, a chronic inflammatory disease of the arterial wall, is found early in life and 
early in human history (McGill, Herderick et al. 2002, Badimon and Vilahur 2014, Wann 
and Thomas 2014). Atherosclerotic plaque formation is a distinct process with defined 
stages of development:  (i) cholesterol deposition (fatty streak formation), (ii) 
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inflammation, (iii) formation of the extracellular atherosclerotic matrix and (iv) thrombosis 
(Libby 2002). Fatty streaks composed of macrophage foam cells are present in the 
arteries of about one-third of children under 9 years of age, and by their late 20s, one-
third of young adults will have well-developed raised lesions with large extracellular lipid 
cores and fibromuscular caps (McGill, McMahan et al. 2000). The multi-center 
Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research study found 
atherosclerotic lesions in all aorta and half of the right coronary arteries of 15 to 19 year-
olds who died of external causes (PDAY 1993). AT is not unique to modern societies as 
the presence of AT has been documented in mummies from multiple cultures and from 
multiple millennia (Clarke, Thompson et al. 2014, Piombino-Mascali, Jankauskas et al. 
2014, Wann, Thompson et al. 2014, Wann and Thomas 2014). The earliest record of AT 
is found in the 5,300 year old mummified remains of the Tyrolean “Iceman” who was 
also found to have several single nucleotide polymorphisms known to predispose 
modern humans to AT (Wann, Thompson et al. 2014). Evidence of AT in the mummified 
remains of other hunter-gather societies raises doubt to the assertion that cardiovascular 
disease arose with the advent of agriculture (Ridker Paul 2002, Wann and Thomas 
2014).  
The renown 19th century pathologist, Rudolph Virchow, was the first to contend 
that inflammation plays a key role in the development of AT (Wann, Thompson et al. 
2014). With the use of modern technology, evidence of parasitic, viral and microbial 
infection has been detected in ancient mummified remains (Thomas, Wann et al. 2014). 
An emerging paradigm in modern medicine implicates infection as a contributor to 
atherogenesis either through direct infection of vascular cells or by the direct effects of 
cytokine induced inflammation resulting from infection at non-vascular sites (Rosenfeld 
and Campbell 2011, Kozarov 2012, Jonsson and Backhed 2017). Both oral and gut 
microbiota have been associated with AT (Slocum, Kramer et al. 2016, Jonsson and 
Backhed 2017, Aarabi, Heydecke et al. 2018). A meta-analysis of 63 studies confirmed 
the presence of 23 oral bacterial species in AT plaque samples (Chhibber-Goel, Singhal 
et al. 2016). S. mutans is among the oral bacteria found in AT plaques and in cardiac 
valves in cases with IE (Nakano, Inaba et al. 2006, Nakano, Nemoto et al. 2007, 
Nakano, Nemoto et al. 2009, Nomura, Naka et al. 2013, Chhibber-Goel, Singhal et al. 
2016, Otsugu, Nomura et al. 2017, Inenaga, Hokamura et al. 2018). The earliest 
documented cases of S. mutans associated IE were published by Abercrombie and 
Scott in the 1920’s, and subsequent confirmatory reports appear in more modern times 
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(Lockwood, Lawson et al. 1974, Aviles-Reyes, Miller et al. 2017). In addition to S. 
mutans, other streptococci, Staphylococcus aureus, enterococci and other 
microorganisms have been linked to IE (N'Guyen, Duval et al. 2017). Although S. 
mutans has been associated with AT and IE, it is not the sole microbe found in these 
diseased tissues, which suggests that perhaps AT and IE result from repeated infections 
by single or multiple members of the microbial community. 
 
NICOTINE ENHANCES S. MUTANS BIOFILM GROWTH 
Chapter 2 of this work is a review of the effects of nicotine on oral 
microorganisms and oral tissues. Nicotine enhances biofilm production by S. mutans 
and many other oral bacteria as well as the oral yeast, Candida albicans (Table 2.1). 
The effect of nicotine on biofilm is not universal as Li et. al. reported it had no effect on 
Streptococcus sanguinis biofilm production (Li, Huang et al. 2014). The S. mutans 
strains in the present collection produced peak biofilm mass and metabolic activity in the 
presence of 4 or 8 mg/ml nicotine, and there were no significant differences between 
serotypes k and c. The nicotine doses producing peak biofilm mass and metabolic 
activity are identical to those previously reported by Huang et al. for S. mutans serotype 
c, e and f strains (Huang, Li et al. 2012, Huang, Li et al. 2015). The CLSM studies with 
six strains of S. mutans showed nicotine significantly increased bacterial mass but did 
not have a significant effect on EPS production. This is in contrast to previous studies of 
S. mutans strain UA159 in single- and dual-species biofilm that reported increases in 
both bacterial mass and EPS in the presence of nicotine (Li, Huang et al. 2014, Huang, 
Li et al. 2015). A possible explanation for the discrepancy is that perhaps the nicotine 
induced increase in EPS production is a characteristic of UA159, which is not evident in 
all strains of S. mutans.  
A new perspective on the effects of nicotine on S. mutans is consideration of the 
combined effects of nicotine and presence of CBP on S. mutans biofilm. The presence 
of 4 mg/ml nicotine and either cbm or cnm resulted in increased biofilm mass and 
metabolic activity compared to strains with neither or both CBP. There was no difference 
in metabolic activity between cmn+ and cbm+ strains. The biofilm mass of cnm+ strains 
was increased compared to cbm+ strains, and the increase appears to be the result of 
an increase of EPS rather than bacterial mass. Exposure to nicotine during biofilm 
development had no effect on the ability of S. mutans to invade endothelial cells 
regardless of the presence or absence of CBP. Nicotine upregulates certain S. mutans 
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virulence genes, increases lactate production and upregulates sortase A, a 
transpeptidase that covalently links surface proteins with LPXTG domains to the cell wall 
of gram-positive bacteria (Li, Huang et al. 2013, Li, Huang et al. 2016). Concomitant with 
sortase A upregulation, UA159 expression of PA I/II is increased. Cbm and Cnm also 
have LPXTG domains (Aviles-Reyes, Miller et al. 2017); thus, increased surface 
expression of Cbm and Cnm was predicted based upon upregulation of sortase A in the 
presence of nicotine. Preliminary collagen-binding assays indicate that nicotine does 
upregulate collagen binding by S. mutans UA159 and many of the other strains used 
here. Exposure to nicotine during biofilm development had no significant effect on 
endothelial cell invasion by any of the 10 S. mutans strains tested regardless of the 
presence or absence of CBP or PA I/II. It is possible that increased expression of CBP 
does not enhance the ability of S. mutans to invade endothelial cells. Alternatively, 
upregulation of sortase A may not significantly increase CBP surface expression. 
Additional studies by both RT-PCR and western-blotting methods measuring Cbm and 
Cnm expression subsequent to nicotine exposure might shed light on the effects of 
nicotine on CBP expression.  
 
ARGININE AFFECTS S. MUTANS BIOFILM STRUCTURE 
The amino acid, arginine, is present in saliva and is found within the endothelial 
glycocalyx in cardiovascular tissues (Van Wuyckhuyse, Perinpanayagam et al. 1995, 
Tarbell and Pahakis 2006, Flam, Eichler et al. 2007, Sharma, Lavender et al. 2014). 
Studies of sucrose-induced biofilm of S. mutans serotype c strains found that addition of 
arginine resulted in increased biomass but altered adhesive and structural properties, 
which may be partly due to decreased EPS production (Sharma, Lavender et al. 2014, 
Zheng, Cheng et al. 2015). Arginine causes down regulation of S. mutans UA159 genes 
responsible for attachment including PA I/II (SpaP) and decreases environmental stress 
tolerance (Chakraborty and Burne 2017). The 33 strains in this study showed no 
significant difference in biomass or metabolic activity when 10 mg/ml arginine was added 
to TSBS (Chapter 3). CLSM studies of S. mutans biomass and EPS production support 
these observations. When the presence or absence of CBP were considered in the 
analysis, biofilms grown in the presence of arginine were like biofilms produced in TSBS 
alone.  
The most interesting effects of arginine on S. mutans biofilm occurred when it 
was combined with nicotine. Simultaneous addition of 10 mg/ml arginine and 4 mg/ml 
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nicotine resulted in significantly decreased S. mutans and EPS compared to nicotine 
alone for the six strains used in the CLSM studies. In the larger study, S. mutans strains 
with the cmn gene showed significantly enhanced biofilm mass and metabolic activity 
when arginine was added with nicotine compared to biofilm grown in nicotine alone. In 
contrast, for the cbm+/cnm- and cbm-/cnm- strains, the addition of arginine to nicotine 
had essentially no effect on nicotine increased biofilm mass and metabolic activity. As 
the CLSM study contained a single cnm+ strain, the effects of this gene on biofilm mass 
and metabolic activity may not be apparent in the CLSM study.  
As with nicotine alone, addition of arginine with or without nicotine had no overall 
effect on endothelial cell invasion by 10 selected strains of S. mutans. A significant 
reduction in endothelial cell invasion was observed for only TLJ60a and TLJ106-1 when 
grown with arginine, and addition of nicotine negated the statistical significance. The 
effects of arginine and arginine with nicotine observed in the biofilm mass, metabolic 
activity and CLSM experiments did not translate to changes in endothelial cell invasion.  
The effects of post-sonication washes of S. mutans prior to the endothelial cell 
invasion assay are intriguing (Figure 5.6). Certain strains displayed significant increases 
in endothelial cell invasion with the addition of post-sonication washes. Inasmuch as 
endothelial cell invasion is based upon the percentage of the individual inoculum that 
invaded the endothelial cells, loss of bacteria is not a likely explanation for the increase 
in invasion associated with the additional washes. It is likely that removal of components 
of the biofilm EPS matrix contributed to the increased ability of certain strains to invade 
endothelial cells. The EPS matrix is composed of polysaccharides, proteins, nucleic 
acids and lipids (Flemming and Wingender 2010). The nucleic acids, or eDNA, in the 
matrix adsorb to the surface of individual bacterial cells in long loop structures that 
extend up to 300 nm from the surface and influence the hydrophobicity of the bacterial 
cell (Okshevsky and Meyer 2015). Removal of eDNA by washing the inoculum might 
positively affect endothelial cell invasion by removing steric hinderance posed by long 
loops of eDNA adhered to the S. mutans or by normalizing hydrophobicity of the 
bacterial cell. Residual proteins and rigid EPS structure in the unwashed post-sonication 
inoculum may represent additional physical barriers that prevent direct interaction 
between the S. mutans cell wall and the endothelial cell. Wu and colleagues 
demonstrated that biofilm formation, autolysis and eDNA production by Streptococcus 
epidermidis were all enhanced in the presence of nicotine in similar doses as used in 
this study (Wu, Ma et al. 2018). This observation may explain the lack of increased 
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endothelial cell invasion by nicotine treated S. mutans biofilm cells such that nicotine 
increased eDNA production interfered with endothelial cell invasion. Addition of post-
sonication washes or DNase treatment of the S. mutans prior to introduction to the 
endothelial cells might clarify the role of S. mutans eDNA in endothelial cell invasion. 
 
S. MUTANS BIOFILM DIFFERS FROM THE  PLANKTONIC STATE 
Bacterial cells growing in planktonic and biofilm states express unique 
phenotypes characterized by differences in gene expression between planktonic and 
biofilm cells (Shemesh, Tam et al. 2007, Shemesh, Tam et al. 2010, Khan, Islam et al. 
2011, Flemming, Wingender et al. 2016, Florez Salamanca and Klein 2018). In 
transitioning from planktonic to biofilm growth, microorganisms undergo major 
transcriptional and proteomic changes (Wright, Burns et al. 2013). In  microarray 
analyses of strain UA159, Shemesh and colleagues discovered differential expression of 
12% of S. mutans genes between biofilm and planktonic cells (Shemesh, Tam et al. 
2007). In the biofilm lifestyle, gene expression varies by the surface colonized, whether 
grown in flow or static conditions and as the biofilm matures with increasing thickness 
(Motegi, Takagi et al. 2006, Shemesh, Tam et al. 2007, Shemesh, Tam et al. 2007, 
Shemesh, Tam et al. 2008, Shemesh, Tam et al. 2010). Further, the variability in 
expression of each gene is higher for biofilm than planktonic cells reflecting the inherent 
heterogeneity of biofilms and the difficulties in obtaining repeatable results with biofilm 
cells (Svensater, Welin et al. 2001). Consequently, bacteria within a biofilm behave 
differently from planktonic bacteria, and properties observed in biofilm are often not 
predictable by study of the same bacteria in planktonic culture (Bowen and Koo 2011, 
Flemming, Wingender et al. 2016). 
Previous studies of endothelial cell invasion by S. mutans cells were performed 
with planktonic cultures grown in a variety of media (Stinson, Alder et al. 2003, 
Abranches, Zeng et al. 2009, Abranches, Miller et al. 2011, Nagata, de Toledo et al. 
2011, Lapirattanakul, Nomura et al. 2013, Nomura, Naka et al. 2013). This is the first 
study to investigate endothelial cell invasion by sucrose-induced S. mutans biofilm. 
Within-strain comparisons demonstrated different rates of endothelial cell invasion 
dependent upon the lifestyle of the invading S. mutans. For six strains, increased 
endothelial cell invasion was obtained by free-cell state S. mutans. In contrast, four 
strains demonstrated superior invasion by S. mutans biofilm. These observations 
exemplify the diversity among strains of S. mutans and suggest the need for 
 
89 
comparative gene expression studies of planktonic and biofilm lifestyles across a larger 
number of S. mutans strains. In particular, focus on genes associated with endothelial 
cell invasion such as cnm, cbm, PA I/II and others may be useful toward understanding 
why strains with similar genetic profiles display different rates of endothelial cell invasion 
and how lifestyle influences the rate of invasion. 
S. mutans is a highly genetically and phenotypically diverse species with a core 
genome consisting of 1,370 to 1,490 genes (Cornejo, Lefebure et al. 2013, Song, Wang 
et al. 2013). In a study of 57 strains, Cornejo et. al. identified an average of 1,636 genes 
per strain leading to an estimated pan-genome of 3,296 genes (Cornejo, Lefebure et al. 
2013). Similar to many other Streptococcus species, different strains of S. mutans have 
highly dynamic genomes with the overall gene composition differing from one isolate to 
another as a result of lateral gene transfer and possibly other mechanisms. The 
distribution of putative virulence genes in 183 S. mutans isolates did not correlate with 
caries status, indicating that other factors play a role in caries development (Meng, Lu et 
al. 2017). Meng and colleagues state that the SpaP gene (PA I/II) is dispensable as it is 
found in isolates from oral cavities with and without caries (Meng, Lu et al. 2017). 
Inasmuch as cbm and cnm are not present in all S. mutans strains, these must be 
considered dispensable, or non-core, genes as well. As exemplified in the strains used 
in this dissertation, the presence of cbm or cnm alone is not sufficient to confer the ability 
to invade endothelial cells upon a particular strain (e.g., AT1, LJ23, 548-1-PBT-05-04). 
Similarly, absence of PA I/II in the presence of cbm or cnm (e.g., SA31, AT1) does not 
necessarily allow a strain to invade endothelial cells. To the contrary, TLJ106-1 (PA I/II+, 
cbm-, cnm-) demonstrated endothelial cell invasion whether this strain was free-living or 
in a sucrose-dependent biofilm. In a previous study, TLJ106-1 demonstrated extremely 
low binding to type I collagen, indicating that a mechanism other than binding to type I 
collagen is involved in the endothelial cell invasion by this strain (Lapirattanakul, Nakano 
et al. 2011). These findings suggest that TLJ106-1 possesses an, as yet unidentified, 




Research is an investigative process in which known facts inform new questions 
leading to novel experiments with which to reach additional conclusions. As such, 
research is a continuous cycle of study, formulation of questions and design of 
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experiments to seek answers or the next questions. The research described herein is 
not different, many questions and opportunities for additional query have evolved 
through the course of my studies. A short, and most likely incomplete, summary of “next 
questions” follows. 
1. Larger scale comparative investigations of S. mutans in planktonic and 
biofilm states using serotypes c, e and f strains would help to determine 
whether the differences in endothelial cell invasion are serotype and lifestyle 
related.  
2. My studies and those of others show strain-to-strain differences in EPS 
production by S. mutans biofilm. Nicotine increases biofilm mass and arginine 
creates a more fragile EPS matrix. These findings lead to questions of 
whether strain specific components of the EPS (i.e., eDNA, glucans, lipids or 
proteins) affect the ability of each strain to invade endothelial cells. Washing 
S. mutans biofilm post-sonication to remove EPS components before 
commencing with the endothelial cell invasion assay will begin to address this 
question.  
3. Strain TLJ106-1 affords the opportunity to identify additional virulence factors 
involved in endothelial cell invasion.  
4. This dissertation focused on the effects of nicotine and arginine on S. 
mutans; however, the effects of the same on the endothelial cell may prove to 
reveal important mechanisms within the endothelial cell that affect its 
receptivity to invasion by bacteria.  
This dissertation is not an ending. It opens the door to additional investigations 
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